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ABSTRACT
THE CLINICAL CORRELATES OF BIOLOGICAL MEASURES OF DEPRESSION
SEPTEMBER 1989
JAN E. LERBINGER, B.A., BOSTON UNIVERSITY
M.S., UNIVERSITY OF MASSACHUSETTS
Directed by: Professor Bonnie R. Strickland
Relationships between four biological measures (post-
dexamethasone Cortisol, urinary free Cortisol (UFO, 3-methoxy-4-
hydroxyphenylglycol (MHPG), platelet monoamine oxidase activity
(MAO)) and clinical symptoms of depression were examined in a
total group of 83 drug free depressed patients (62 female, 31
male), a subgroup of 67 unipolar major depressed patients, and in
female and male patients within these two groups. Patients were
rated using the Hamilton Rating Scale for Depression (HRSD), the
Schedule for Affective Disorders and Schizophrenia (SADS), and
were diagnosed using Research Diagnostic Criteria (RDC) or other
clinical data. Data were analyzed using Spearman correlations,
multiple regression analyses, discriminant function analyses,
analysis of variance, and Chi Square.
Overall, stronger relationships were observed between the
biological measures and specific clinical symptoms than with
global ratings of either endogeneity or severity of illness.
Several variables were observed to be significantly correlated
with the biological measures in the unipolar group of patients
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but not in the total group, and in some cases stronger
associations were observed in the unipolar group as compared to
the total group of patients. A greater number of significant
correlations were observed between the biological measures and
clinical symptoms in the female group of patients than in the
male subgroup.
Post-dexamethasone Cortisol was most strongly positively
related to psychosis, and negatively to somatic anxiety, and
guilt. Urinary free Cortisol was most strongly negatively
associated with overt anger, subjective anger and agitation, and
positively with suicidal tendencies. The strongest relationships
between MHPG and clinical features were observed in a positive
direction between MHPG and agitation and obsessionality. Platelet
MAO activity was most strongly negatively associated with somatic
anxiety, somatic symptoms and paranoia, and positively with
current suicidality. Of the four biochemical measures, only
platelet MAO activity was observed to be significantly higher in
patients with higher ratings of current suicidality (using the
HRSD suicide item) in comparison to patients with lower ratings
of current suicidality. Overall these data point to complex
relationships between biological measures and clinical
correlates.
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CHAPTER I
INTRODUCTION
Major depressive disorder is a complex psychobiological
syndrome with multiple etiologies and presentations. The disorder
involves mood disturbance, various neurovegetative signs, and
often cognitive changes. Physiological theories of major
depressive disorder have examined impairment of brain
neurotransmitters and hormonal systems, as well as circadian
rhythm and REM sleep (Schulberg et al., 1987). Recently, attention
has been paid to clinical laboratory tests which serve as
biological measures of depression. Determining the relationship
between these biological measures and major depression is an
important area of research, one that has been limited by the
seemingly broad label of major depression. Attempts to look at
specific major depressive subtypes have been limited by questions
of the validity of these subtypes (Davidson et al., 1985;
Zimmerman et al., 1985), the heterogeneity of major depressions
(Nelson & Charney, 1981; Schatzberg et al., 1982), and the
continuing question of whether laboratory findings relate more to
syndrome than to specific symptoms or overall severity.
Information gained from research in this area may help to
elucidate the etiology of major depressive disorders, as well as
aid in determination of effective mechanisms for treatment
(Redmond et al., 1986).
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Several biological measures of depression have been the
focus of study. The dexamethasone suppression test (DST) has been
one of the most extensively researched, and has been used to
evaluate dysfunction of the hypothalamic-pituitary-adrenal (HPA)
axis in depressed patients. The measure of urinary free Cortisol
(UFO has also been used to evaluate HPA dysfunction and has the
advantage of providing an integrated measure of Cortisol secretion
over time. Another line of investigation has been the measurement
of disturbances of noradrenergic neurons in the central nervous
system. One such measure is 3-methoxy-4-hydroxyphenylglycol
(MHPG), the major metabolite of norepinephrine in the brain.
Platelet monoamine oxidase (MAO), the enzyme that deaminates
catecholamines and indolamines has also attracted considerable
interest as a biological marker of depression.
While much research has been conducted on these biological
measures, few have related the findings to the clinical
characteristics of major depressive disorder. Of the studies which
have examined the relationship of these measures to clinical
phenomena, most have focused on an endogenous or melancholic
depressive syndrome. This approach may have limitations, however,
resulting from a lack, of agreement among researchers in the
clinical diagnosis of endogeneity or melancholia, despite the aid
of operational definitions (Davidson et al., 1986; Zimmerman et
al, 1986). Casper et al. (1986) for example, found that "the
classic somatic symptoms of depression were present in most
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Research Diagnostic Criteria (RDC) subtypes, and were not
exclusively associated with the endogenous subtype" (p. 1098).
The uncertainty in clinical diagnosis, and the confounding
effect of severity of depression in both the diagnosis of
endogenous depression (Kumar et al., 1986), and the biological
abnormalities themselves, may in part account for the discrepant
findings in studies relating biological measures to clinical
diagnosis (Davidson et al., 1985). An alternative to the study of
diagnostic subtypes is to examine the relationship between
biological variables and specific signs and symptoms of major
depressive disorder (Davis et al
.
, 1981). For example, a promising
area of research has been the study of the relationship between
biological measures of depression and suicide. While this has
proved a worthwhile avenue of investigation, Ross (1986) warns
against "dealing with symptoms or syndromes as if they were
specific diseases" reflecting "specific biological entities" (p.
431)
.
A review of the major literature concerning relationships
between biological measures of depression and endogeneity,
severity of illness, and specific endogenous or nonendogenous
symptoms will be provided. Suicide will be discussed separately,
as it is of greater clinical significance than other nonendogenous
symptoms. A review of the previous literature may point to the
most useful approach for further study of the relationship between
biological measures and clinical features of major depressive
disorder.
3
Dexamethasone suppressj^ n t?gt
The dexamethasone suppression test has received widespread
attention in psychiatry since Carroll et al
. (1981) first
presented data on the standardization of this test in melancholic,
other psychiatric, and normal control subjects. The DST is
generally considered a state marker of depression, and following
the paper of Carroll et al. (1981), most researchers have defined
an "abnormal" DST or "non-suppression" as a post-dexamethasone
Cortisol level above 5 ug/dL, while a level below 5 Fg/dL is
defined as DST "suppression". The extensive interest in the DST
has resulted in considerable debate regarding its usefulness in
clinical practice. In a review article in which Arana et al.
(1985) examined 232 citations involving 4,463 psychiatric cases,
it was concluded that "neither uncritical enthusiasm nor excessive
skepticism about the DST presently is warranted" (Arana et al.,
1985, p. 1200).
Much of the research on the DST has focused on the
relationship between non-suppression of Cortisol and the
melancholic or endogenous subtype of depression (Braddock, 1986;
Carroll et al., 1981). Carroll et al. (1981) originally reported
that the use of the DST as a laboratory diagnostic test for
melancholia had a "sensitivity greater than 66%" and a
"specificity and diagnostic confidence close to 95%" (p. 22).
Subsequent reports have provided conflicting evidence. Several
studies have found a significant increase in the nonsuppression
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rate among endogenous patients (Coryell et al., 1982; Feinberg &
Carroll, 1984; Zimmerman et al., 1985; Zimmerman et al
. , 1986;
Zhou et al., 1987). Other data suggests that DST non-suppression
is not specific to melancholia or endogeneity as a diagnostic
state (Berger et al., 1982; Miller & Nelson, 1987; Nasr et al
.
,
1983; Roy et al
. , 1984; Rubin et al., 1985). As discussed
previously, these conflicting results are in part attributable to
a lack, of diagnostic consistency. Braddock (1986) reports that
"the criteria employed by the Newcastle Scale and by Carroll's
group seem more successful" at identifying endogenous patients
showing a higher rate of nonsuppression, "than the present state
criteria of the RDC, DSM-III, and ICD" (p. 367).
One possible explanation for the association of non-
suppression on the DST and endogenous depression is that
endogeneity is confounded with severity of illness (Kumar et al.,
1986) , with endogenously depressed patients being more severely
depressed than nonendogenous patients (Braddock, 1986). Several
studies have reported a positive relationship between severity of
illness and DST non-suppression (Baumgartner et al., 1986; Brown
et al., 1979), as well as positive correlations between post-
dexamethasone Cortisol values and severity of illness (Davis et
al., 1981; Kumar et al., 1986; Maes et al., 1986; Zhou et al.,
1987) . Other evidence has suggested a lack of association between
either non-suppression on the DST or post-dexamethasone Cortisol
levels and severity of illness (Berger et al., 1982; Brown &
Shuey, 1980; Larsen et al . , 1985). Despite the conflicting
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findings, Braddock (1986) concludes that "the evidence so far does
suggest a relationship between Cortisol level and severity" (p.
367)
.
The study of specific symptoms and their relationship to the
DST has been an important area of research. Miller & Nelson (1987)
found that individual symptoms were more closely associated with
DST results than were subtypes, severity or behavioral factors.
Several studies have examined the association between the DST and
symptoms which serve as criteria for the RDC subtype of endogenous
depression. These criteria as defined by Spitzer et al. (1978)
are: distinct quality to depressed mood, lack of reactivity to
environmental changes, mood regularly worse in morning, pervasive
loss of interest or pleasure, self reproach or guilt, early
morning awakening, psychomotor retardation or agitation, weight
loss and loss of interest and pleasure (nonpervasive)
.
Positive relationships between the DST and specific
endogenous symptoms of depression have been found. Studies which
have examined these relationships are summarized in Table 1 (p.
11), and are discussed in greater detail here. Reus (1982)
reported that "independent of diagnosis, non-suppressors are noted
to have a greater incidence of classical endogenous signs of
dysfunction on admission and a greater incidence of subjective
complaints" (p. 317). Among the differences Reus (1982) reported
were increased sleep disturbance, anergy, agitation, loss of
interest, and self reproach in the non-suppressors as compared to
the suppressors. Asnis et al. (1982) described "hypothalamic
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signs" consisting of insomnia, poor appetite, psychomotor
retardation and worsening of mood in the morning, and reported
that these symptoms were significantly higher in non-suppressors.
Rubin et al. (1985) found that post-dexamethasone Cortisol values
were positively correlated with observed psychomotor retardation,
lack of responsiveness during the interview, weight loss,
diminished work and activities and insomnia. In addition, non-
suppressors had significantly more terminal insomnia (early
morning awakening) and diurnal variation than suppressors.
Christensen et al
.
(1986) reported an association between post-
dexamethasone Cortisol levels and the HDS-6 (a sum of the Hamilton
Rating Scale for Depression (HRSD) items depression, guilt, work
and interests, retardation, anxiety psychic and somatic general),
as well as a positive correlation between retardation (sum of
items work and interests and retardation). Several other
researchers have noted a positive association between psychomotor
disturbance (retardation or agitation) and either non-suppression
on the DST or post-dexamethasone Cortisol levels (Agren & Wide,
1982; Zimmerman et al
.
, 1986).
Reports also exist of a lack of relationship between the DST
and endogenous symptoms (see Table 1, p. 11). Asnis et al. (1982)
did not find that suppressors and non-suppressors differed in
endogenous features. While Brown and Shuey (1980) noted that
suppressors had greater diurnal variation, they also reported that
suppressors and non-suppressors did not differ in the endogenous
symptoms of agitation, retardation or insomnia. Kaspar & Beckmann
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(1983) also failed to find differences between suppressors and non-
suppressors on measures of retardation, agitation, work and
interests, and Brown & Quails (1981) reported no differences
between these groups on measures of appetite loss, guilt,
insomnia, psychomotor activity, weight loss, diurnal variation,
and mood. Finally, Grunhaus et al. (1985) did not find any
significant relationship between post-DST plasma Cortisol and
either early morning awakening or diurnal variation.
Nonendogenous symptoms of depression have also been the focus
of study. Major findings from these studies are summarized in
Table 1 (p. 11). Several researchers have examined the
relationship betwen anxiety and post-dexamethasone Cortisol
levels. Positive relationships have been reported between non-
suppression on the DST and anxiety in some studies (Ceulemans et
al., 1985; Christensen et al., 1986; Reus, 1982), but not in
others (Asnis et al., 1982). Brown & Shuey (1980) and Brown &
Quails (1981) found significant differences between suppressors
and nonsuppressors in the ability to complete self-rating forms,
with the non-suppressors being more unable to complete the forms,
and exhibiting a greater degree of helplessness. Silberman et al.
(1985) found, contrary to expectation, that suppressors showed a
larger degree of cognitive impairment than non-suppressors.
There does not appear to be consistent evidence regarding the
relationship of the DST to either specific endogenous or
nonendogenous symptoms of depression. In the attempt to elucidate
the relationship between specific clinical signs and symptoms and
8
dysfunction of the HPA system as measured by the DST, two studies
(Nasr et al
.
,
1983: Zimmerman et al., 1985), have used a different
methodological approach, conducting discriminant function analyses
on their data.
Zimmerman et al
.
(1985) attempted to develop a discriminant
function that "maximally differentiated between suppressors and
non-suppressors" (p. 200) on the DST. They conducted the
discriminant function analysis on the 10 RDC criteria for the
endogenous subtype, using DST results as the independent variable.
They found that only five of the ten endogenous symptoms were
significant contributors to the discriminant function separating
suppressors and non-supppressors
. Four of the five symptoms were
scored in the positive direction (mood worse in morning, middle or
terminal insomnia, psychomotor disturbance, poor appetite), and
only one symptom (pervasive or non-pervasive anhedonia) was
weighted negatively.
While Zimmerman et al . (1985) limited their study to
endogenous symptoms, Nasr et al. (1983) included all the items on
the HRSD in their analysis. In an attempt to "test the hypothesis
that the DST accurately identifies distinct subgroups of clinical
depression having particular signs and symptoms as measured by the
HRSD" (p. 572), Nasr et al. were able to classify patients into
suppressors and non-suppressors with an accuracy of 92.5%. "The
items that identified the non-suppressors in decreasing power were
late insomnia, obsession-compulsion, retardation, psychic anxiety,
and loss of insight. The items that accurately identified the
9
suppressors were depressed mood, hypochondriasis, weight loss and
depersonalization" (p. 572).
Although the number of subjects in the Nasr et al. (1983)
study was considerably smaller (N=40) than that of the Zimmerman
et al. (1985) study (N=257), and could have affected the validity
of the results, the Nasr et al. study, does suggest the importance
of including nonendogenous as well as endogenous variables in
future analyses. The recent study by Miller & Nelson (1987) also
supports this conclusion. They reported that DST nonsuppression
was associated with certain "vegetative" signs of depression
(initial insomnia, agitation, loss of sexual interest and weight
loss), but not with the "psychological" symptoms (loss of
interest, anhedonia and guilt).
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Table 1
STUDIES OF THE RELATI ONSHIP BETWEEN POST-nKXAMETHASONP: rnPTT.qnT.
AND ENDOGENOUS AND NONENDOGENOUS SYMPTOMS ~
Study Findings
Reus (1982) Non-suppressors on DST had N = 118
increased sleep disturbance,
anergy, agitation, loss of
interest, self reproach, and
anxiety as compared to suppressors
Asnis et al
. Non-suppressors on DST had N = 30
(1982) increased insomnia, poor lo Males
appetite, and psychomotor 20 Females
retardation
Rubin et al
. Post-dexamethasone Cortisol n = 64
(1986) positively correlated with 31 Males
psychomotor retardation, lack. 33 Females
of responsiveness during interview,
weight loss, and diminished work and
activities; non-suppressors had
increased early morning awakening
and diurnal variation
Christensen Significant association between N = 35
et al. (1986) post-dexamethasone Cortisol 12 Males
and HSD-6 score, 23 Females
retardation, and psychic anxiety
Agren & Wide Non-suppression on DST associated N = 51
(1982) positively with summed score of
agitation and retardation
Zimmerman et DST results positively related N = 257
al. (1986) to psychomotor disturbance
Asnis et al. Non-suppressors and suppressors N = 40
(1982) on DST did not differ in 11 Males
severity of endogenous features 29 Females
^ HDS-6 = A sum of Hamilton Rating Scale for Depression items
depression, guilt, work and activities, retardation,
anxiety psychic, and somatic general
continued next page
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Table 1 (continued)
STUDIES OF THK RELATIONSHIP BETWEEN Pne^T-QEXftMRTHftsnMir CORTISOL
AND ENDOG ENOUS AND MQMEMnOfiRMQUS Svi^F^
ft«M i^SONE r T
Study Findings
Brown & Shuey
(1980)
Kaspar &
Beckman (1983)
Suppressors on DST had greater N = 49
diurnal variation; no difference 39 Males
between suppressors and non- lo Females
suppressors on ratings of
agitation, retardation or
insomnia; non-suppressors were
more unable to complete rating
forms and had greater degree of
helplessness
No difference between suppressors N = 67
and non-suppressors on measures 15 Males
of retardation, agitation, and 52 Females
work and interests
Brown & Quails
(1981)
No difference between suppressors
and non-suppressors on measures of
appetite loss, guilt, insomnia,
psychomotor activity, weight loss,
diurnal variation and mood; non-
suppressors more unable to complete
rating forms and had greater degree
of helplessness
N = 39
8 Males
31 Females
Grunhaus et al
(1985)
No significant relationship between
post-dexamethasone Cortisol and
either early morning awakening or
diurnal variation
N = 49
Ceulemans
et al. (1985)
Higher levels of anxiety in DST
non-suppressors than in controls
N = 40
23 Male
17 Female
20 controls
Silberman et
al. (1985)
Suppressors showed larger degree of N = 27
cognitive impairment than non- 8 Males
suppressors 19 Females
Zimmerman et
al. (1986)
Psychomotor retardation and
depressed mood significantly
greater in non-suppressors
N = 187
65 Males
132 Females
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Dexamethasone suppression test and suicidp
One of the most extensively researched areas in the
examination of the relationship between clinical characteristics
of depression and altered biochemistry, has been the study of
suicide and suicidal behavior. Several studies have examined the
association between suicidal behavior and HPA dysregulation as
measured by the DST. These studies have included suicide
completers, suicide attempters, and suicide contemplators
. While
these groups may appear to be distinct, they may in fact represent
a continuum of suicidality. Stallone et al. (1980) for example,
found that "attempters and contemplators were a good deal more
similar to one another than either one was to the nonsuicidals"
(p. 386).
Several studies have found a relationship between suicide and
non-suppression on the DST. Coryell & Schlesser (1981) in one of
the few studies to examine biological abnormalities in suicide
completers, found a higher incidence of suicide completion in
patients with abnormal DST's. Due to the length of time however
between the DST and the actual suicide completion, these results
must be regarded as equivocal. Others have examined past suicide
attempts, and have found a greater rate of non-suppression in
suicide attempters vs. non-attempters (Banki et al., 1984; Targum
et al., 1983), and in "violent and nonviolent " attempters vs.
nonsuicidal patients (Banki et al., 1984). Reus (1982), in the one
study to find a positive association between the DST and
13
suicidal ity assessed at the time of biochemical measurement,
reported that DST non-suppression was associated with
"increased thoughts of suicide", thus suggesting the relationship
between HPA dysfunction and suicide "contemplators"
.
Other researchers have failed to confirm the positive
association between DST non-suppression and either past or present
suicidal ity. Secunda et al. (1986) found no significant
differences between suicide attempters and non-attemptors in post-
dexamethasone Cortisol levels. They did find significantly lower
pre-dexamethasone levels in the suicide attempters however. Brown
et al. (1986) studied three groups of patients: patients who had
recently attempted suicide (within 28 days before the DST), past
attempters, and non-attempters, and found that plasma Cortisol
levels did not differ significantly between the three groups. They
also found that there were no significant differences in mean
Cortisol levels between "patients rated as having active suicidal
intent" (on HRSD suicide item) and "patients with passive or no
suicidal ideation" (p. 319). Zimmerman et al. (1986) reported that
there were no significant differences between suppressors and non-
suppressors on the DST in either frequency of past suicidal
thoughts or serious past suicide attempts. They did find that past
nonserious suicide attempts were significantly more frequent in
the suppressors.
The positive relationship between HPA dysfunction and
suicidality has not been well documented. Further research may
help to clarify whether the tendency of depressed patients to
14
attempt suicide may be exacerbated by an underlying
neurobiological disorder reflected by HPA dysregulation, and
whether depressed suicidal patients with abnormal DST's may
represent a high-risk group for recurrence of suicidal behavi
Urinary Free Cortisol
Urinary free Cortisol (UFO, an integrated measure of
Cortisol over time, has also been used to evaluate HPA dysfunction
and may have the potential to yield more information than can be
obtained from occasional blood samples. The study of UFC however,
has received much less research attention than the DST. Studies
examining UFC in patients with major depressive disorder
have generally found elevated levels of UFC as compared to
"normal" controls or patients with other psychiatric disorders
(Carroll et al., 1976; Rosenbaum et al., 1983).
Few studies have been conducted which examine the
relationship between UFC and endogeneity, severity, specific
endogenous symptoms, or nonendogenous symptoms. Those studies
which have examined the relationship between UFC and specific
endogenous or nonendogenous symptoms are summarized in Table 2 (p.
17). Berger et al., (1982) did not find a significant difference
between endogenous and nonendogenous patients in UFC levels.
Kathol (1986) studied recovered depressed patients and controls,
and found a positive correlation between Beck. Depressive symptoms
15
and UFC in the group of recovered patients, but not in the
controls. Agren & Oreland (1982) reported a significant positive
relationship between early morning awakening and UFC, and Berger
et al. (1982) found a positive association between UFC and weight
loss
.
The study of the relationship between suicide and UFC has
also received little attention. Agren & Wide (1982) reported that
UFC was highly significantly correlated with less past suicide
proneness. In addition they found that 20% of the variance of UFC
was explained by the Schedule for Affective Disorders and
Schizophrenia (SADS) items of "seriousness plus medical lethality
of worst ever suicide attempt", "anger worst week.", and "overt
anger last week". UFC was also found to correlate negatively with
anger scores. This study points to the important relationship
between suicide and expression or experience of anger.
16
Table 2
STUDIES OF THE RELATIONSHIP BETWEEN UFC AND ENDOaFMnnq AND
NONENDOGENOUS SYMPTOMS '
Study Findings N
Kathol et al. Positive correlation between N = 7
(1985) UFC and Beck Depression Inventory
score in recovered depressed
patients
Agren & Positive correlation between N = 51
Oreland (1982) UFC and early morning awakening 22 Males
29 Females
Berger et al. Positive association between N = 45
(1982) UFC and weight loss 22 Males
23 Females
17
3-methoxv-4-hvdroxvDhenYl glycol ( MHPn
)
MHPG, the major metabolite of norepinephrine from the brain,
has been measured in plasma, urine, and cerebrospinal fluid (CSF).
Although a substantial portion of plasma and urinary MHPG may be
of peripheral origin (Halbreich et al
. , 1987), with the exact
fraction of urinary or plasma MHPG derived from the brain
uncertain (Schatzberg et al
. , 1982), it is generally agreed that
both urinary and plasma MHPG "have their place in psychiatric
research" (Filser et al., 1986, p. 96).
MHPG has been studied in relation to the monoamine hypothesis
of depression which has suggested that depression is caused by
insufficient activity of monoaminergic neurons. Studies examining
MHPG in major depressive disorder have found differences in
urinary MHPG in various subtypes of depressive disorders
(Schildkraut et al., 1978; Schatzberg et al., 1982), as well as
higher CSF MHPG levels in depressed subjects as compared to
controls (Koslow et al., 1983).
One study has reported on MHPG and its relationship to
endogeneity. Nelson and Charney (1981) comment that "decreased
MHPG may be specific to endogenous depression". More has been
written about MHPG in relation to severity of illness. The
majority of reports have failed to find a significant relationship
between severity and MHPG as measured in urine (Davis et
al.,1981), plasma (Roy et al., 1986) and CSF (Redmond et al..
18
1986). Recently however, Schatzberg et al . (1989) found a
significant main effect for severity on MHPG, with the more
severely depressed patients having higher MHPG values.
Several studies have suggested a positive relationship
between MHPG and endogenous symptoms. A summary of these studies
is presented in Table 3 (p. 21). Agren (1980) found a significant
positive correlation between CSF MHPG and both "distinct quality
of mood" and "lack of energy". Redmond et al. (1986) reported that
sleep disturbance was significantly correlated with CSF MHPG in
depressed patients, and found that depressed patients with
"higher" retardation scores had significantly higher CSF MHPG
concentrations than patients with "low" or "middle" retardation
scores.
Nonendogenous symptoms of depression have also been studied
in their relationship to measures of MHPG (see Table 3, p. 21).
Positive associations between MHPG and anxiety have been reported
(Roy et al., 1986; Redmond et al., 1986). In addition, depressed
patients with increased somatization have been found to have
higher levels of CSF MHPG ( Redmond et al . , 1986). In contrast to
these findings, a study of afternoon continuous plasma levels of
MHPG (Halbreich et al . , 1987) found almost no association between
plasma MHPG and clinical symptoms.
Overall, the research examining MHPG in relation to
endogeneity, severity, and specific endogenous and nonendogenous
symptoms, does not appear to provide a consistent picture. Using a
somewhat different methodological approach to examine the clinical
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correlates of MHPG, Agren (1980), using symptom scores on the
SADS, performed a series of multiple regression analyses. His
results revealed that "high- and low-MHPG syndromes could be
isolated" (p. 211). In his sample of unipolar patients, Agren
identified a "high-MHPG syndrome characterized by Lack of Energy,
Overt Anger, Self Pity and Somatic Preoccupation", and a "low-MHPG
syndrome" characterized by "Discouragement, Demandingness,
Subjective Anger, Suicidal Tendencies, Indecisiveness, and
Obsessions-Compulsions" (p. 218). Again, the use of a more complex
method of data analysis suggests the importance of examining both
endogenous and nonendogenous symptoms simultaneously.
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Table 3
STUDIES OF THE RELRTIQNSHIP BETWEEN MHPG AND FMnnr.FMnnQ and
NONENDOGENOUS SYMPTOMS '
~
Study Findings
Agren (1980) Significant positive correlation N = 33
between CSF MHPG and distinct 12 Males
quality of mood and lack of 21 Females
energy
Redmond et al
. CSF MHPG significantly and N = 99
(1986) positively correlated with sleep
disturbance; patients with higher
retardation scores had significantly
higher CSF MHPG levels than patients
with "low" or "middle" retardation
scores; positive correlation between
MHPG and anxiety; patients with
increased somatization were found to
have higher levels of CSF MHPG
Roy et al . Positive correlation bewteen plasma N = 51
(1986) MHPG and anxiety symptoms 11 Males
40 Females
Halbreich et Almost no association between plasma N = 42
al. (1987) MHPG and clinical symptoms 15 Males
27 Females
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MHPG and suicide
Most of the work exploring the relationship between suicide
and the metabolites of monoamine neurotransmitters has focused on
associations between low levels of the serotonin metabolite, 5-
hydroxindoleacetic acid (5-HIAA) in CSF, and suicidal behavior
(Agren, 1980; Asberg & Traskman, 1981). As a result, less
attention has been paid to MHPG, the metabolite of norepinephrine,
and its association to suicide.
Several studies have found a negative relationship between
MHPG and past suicidal ity. Secunda et al . (1986) reported that
suicide attempters had significantly lower urinary and plasma MHPG
levels than patients who had never attempted suicide. Agren (1980)
also found a negative correlation between CSF MHPG and suicidal
tendencies occurring during the worst week of the current episode.
Mann et al. (1986) observed an increase in P-adrenergic
binding in frontal cortices of violent suicide victims as compared
with matched controls, and stated that "this suggests that there
may also be a concomitant reduction in presynaptic noradrenergic
activity associated with suicide" (p. 954).
In contrast to the findings of a negative association between
MHPG and suicide, Traskman et al. (1981) found no significant
difference in MHPG levels between either of two types of suicide
attempters studied (violent vs. nonviolent), and a control group.
A positive relationship between CSF MHPG and suicide was found by
Brown et al. (1982) in a sample of patients with various
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personality disorders. Brown et al. (1982) found that in
particular, patients with histories of aggressive and suicidal
behavior had higher levels of CSF MHPG. This contradictory finding
may in part be explained by the population of patients studied. A
study by Agren (1980) in which it was found that MHPG correlated
significantly with the SADS item "Suicidal Tendencies also
points to the relationship between suicidal ity and anger or
aggressiveness. Agren (1980) found that "subjective anger was
positively, and overt anger negatively associated with thoughts of
suicide"(p. 225). Agren suggests that noradrenergic neurons
apparently play a role both in the "conveying" of the emotion of
anger, and in "executing the death wish" (p. 235).
Platelet monoamine oxidase activity
Platelet MAO is one of the most extensively researched
enzymes in relation to personality traits and psychiatric
disorders (Agren & Oreland, 1982). It has been of particular
interest to researchers in biological psychiatry as it is the
enzyme that deaminates catecholamines and indolamines. It has been
suggested that MAO activity may "provide some indication of the
turnover of monoamines which, as neurotransmitters, may be
involved in the development of depression" (Georgotas et al.,
1986, p. 247).
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While strong relationships have been found to exist between
platelet MAO activity and personality traits, studies
investigating platelet MAO activity in affective disorders have
been less definitive. Several studies have found platelet MAO
activity to be lower in bipolar depressives (Mann, 1979; Murphy &
Weiss, 1972) and higher in unipolar depressives (Reveley et al.,
1981), particularly females (Bridge et al
. , 1985; White et al
.
,
1983; Mann, 1979).
The relationship between the endogenous or melancholic
subtype and platelet MAO activity has been discussed by several
researchers. Some have found a positive relationship between
platelet MAO activity and endogenous depression. Mann (1979)
discusses the possibility that "altered MAO activity may be a
feature of endogenous rather than reactive depression" (p. 735),
and Samson et al. (1985) report finding significantly higher MAO
in "nonschizotypal unipolar endogenous depressed patients than in
nonschizotypal bipolar endogenous depressed patients, or
nonschizotypal unipolar other patients" (p. 547). In contrast.
White et al . (1983) found higher platelet MAO in nonendogenously
depressed females than in female controls. Davidson et al. (1980)
reported no significant differences in platelet MAO activity
between endogenous and nonendogenous patients, after adjusting for
the effects of age and sex.
The lack of consistency in the studies examining the
relationship between the diagnosis of endogeneity and platelet MAO
activity may again be related to a lack of diagnostic agreement.
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Georgotas et al
.
(1986), for example, in a study of patients > 55
years of age, found no significant difference in platelet MAO
activity between endogenous and nonendogenous patients (using RDC
criteria) after the effects of age and sex had been controlled
for. However, using the DSM-III criteria for major depression with
melancholia, they found that melancholic patients had
significantly higher platelet MAO activity than those without
melancholia, after the effects of age and sex were taken into
account.
The possibility of the confounding effects of severity of
illness on the relationship of platelet MAO activity to
endogeneity has been discussed by several researchers. Some
have reported a significant positive correlation between total
score on the HRSD and platelet MAO activity (Gudeman et al.,
1982;, Mann, 1979; Samson et al., 1985). Samson et al. state that
"the presence of a definite endogenous depressive syndrome was
associated with greater overall symptom severity in both unipolar
and bipolar depressed patients" (p. 547). They suggest that
"unipolar endogenous depression of high severity is characterized
by high platelet MAO activity" (p. 553) as well as nonsuppression
on the DST.
Several studies have reported on the association between
platelet MAO activity and specific symptoms of endogenous
depression. A summary of these studies is presented in Table 4 (p.
28), and discussed in greater detail here. A negative correlation
between platelet MAO activity and guilt has been reported in
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total groups of patients (Perris et al
. , 1980; Schalling et al.,
1980), and in females only (Perris et al., 1984) A positive
correlation between platelet MAO activity and guilt has also been
reported (Schalling et al
. , 1980). Agren & Oreland ( 1982) found
that unipolar patients with higher levels of platelet MAO activity
woke up earlier than they had before becoming depressed.
Schatzberg et al
. (1986) found platelet MAO activity to be
positively associated with early morning awakening, as well as
with difficulty falling asleep, and "middle insomnia". The
endogenous symptoms of anhedonia and mood autonomy were reported
to be positively correlated with platelet MAO activity (Georgotas
et al., 1986), as were the symptoms of depressed mood, weight
loss, agitation, and decreased energy and activity (Gudeman et
al., 1982). With the possible exception of guilt, it appears that
most reports find a positive relationship between some of the
endogenous symptoms of depression and platelet MAO activity.
Many of the studies reporting on nonendogenous symptoms of
depression and their relationship to platelet MAO activity (see
Table 4, p. 28) have focused on anxiety. Davidson et al . (1980)
found platelet MAO activity to correlate positively with anxiety,
and Georgotas et al. (1986) reported that platelet MAO activity
was significantly related to somatic anxiety, but not to psychic
anxiety. Khan et al . (1986) were "unable to demonstrate that MAO-B
activity differentiated among anxious, depressed, or control
subjects" (p. 848), and found a "poor correlation between MAO-B
and severity of anxiety symptoms" (p. 848).
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To further explore the relationship between clinical symptoms
and platelet MAO activity, Gudeman et al. (1982) performed a
multiple regression analysis using 21 items from the Clinical
Inventory for the Diagnosis and Classification of the Affective
Disorders (CIDCAD). They report that "this analysis identified six
clinical items" (p. 631) (abdominal heaviness, decrease in social
activity, agitation, decrease in emotional receptivity, weeping
(with a negative coefficient), and the presence of a major stress
precipitant) "each of which accounted for a significant portion of
the variance of MAO activity" (p. 631). This statistical approach
may yield results which may prove to be of clinical relevance.
Gudeman et al. (1982) report that most of the symptoms they found
to be associated with higher platelet MAO activity (both
endogenous and nonendogenous symptoms) "would be included in one
or more of the clinical features" (p. 532) reported by other
researchers to be responsive to treatment with MAO inhibitors.
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Table 4
STUDIES OF THE RELATIONSHIP BETWEEN PLATF.T.FT MAO ACTTVT TV AND
ENDOGENOUS AND NONRNDOGENOUS SYMPTOMS
'
Study Findings
Perris et al
(1980)
Perris et al
.
(1984)
Agren &
Oreland (1982)
Schatzberg et
al. (1985)
Weak, negative correlation N = 30
between platelet MAO activity 14 Males
and guilt le Females
Negative correlation between N = 143
platelet MAO activity and guilt 60 Males
in females 83 Females
Unipolar patients with higher N = 51
levels of MAO activity woke up 22 Males
earlier than they had before 29 Females
becoming depressed
Platelet MAO activity positively N = 50
correlated with early, middle, and 23 Males
late insomnia 27 Females
Georgotas et
al. (1986)
Positive association between MAO and N = 67
anhedonia, mood autonomy; MAO 24 Males
significantly related to somatic 43 Females
anxiety but not to psychic anxiety
Gudeman et al.
(1982)
Davidson et al
(1980)
Positive correlation between MAO and N = 32
depressed mood, weight loss, 18 Males
agitation, decreased energy and 14 Females
activity
Platelet MAO activity significantly N = 88
higher in depression secondary to 17 Males
chronic anxiety 71 Females
Kahn et al
(1986)
No difference in levels of HAO-B N = 163
activity between anxious, depressed 94 Males
or control subjects; poor correlation 69 Females
between MAO- B and severity of
anxiety symptoms
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Platelet MAO activity and suicidp
Several studies have considered the relationship between
platelet MAO activity and past suicidality, and conflicting
evidence has been found. Low platelet MAO activity has been
reported in depressed patients who have made particularly serious
suicide attempts (Gottfries et al., 1980). Buchsbaum et al. (1977)
found that males with low MAO and AER (averaged evoked response)
augmenting, showed a significantly increased incidence of suicide
attempts in comparison with either non-augmenting low MAO or high
MAO patients. In contrast, Oreland et al. (1981) did not find any
difference in the level of platelet MAO activity between suicidal
and non-suicidal patients. In a study of brain MAO activity, Grote
et al . (1974) "found no significant difference for MAO activity in
28 brain areas when 19 controls were compared with 14 depressives
suicides or with 11 alcoholic studies" (Reveley et al
. , 1981, p.
259)
.
The relationship between platelet MAO activity and suicide
may be complicated by the fact that unipolar and bipolar depressed
patients have been found to have significantly different levels of
platelet MAO activity, as well as different rates of suicide
attempts. Bipolar depressed patients have been reported to be more
likely to attempt suicide than unipolars (Secunda et al., 1986),
and to have lower platelet MAO activity (Mann, 1979; Murphy &
Weiss, 1972). Impulsivity and monotony avoidance have also been
found to be related to lower levels of platelet MAO activity in
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both depressed patients and normal controls (Schalling et al
.
,
1980; Perris et al., 1980; Perris et al., 1983; Perris et al.,
1984), and perhaps are also associated with bipolar depression.
Biologica l measures and their inter-relations^)
,p
The majority of studies have focused on the measurement of
one biological measure of depression in a population of patients.
Several studies have examined two or more biological measures, and
have attempted to understand the inter-relationship between
catecholamine systems, HPA activity, and platelet MAO activity.
Studies of severely depressed patients have reported significantly
positive correlations between Cortisol and MHPG as measured in 24-
hour urine collection or plasma ( Stokes et al., 1981; Jimerson et
al., 1983; Rosenbaum et al
. , 1983; Zhou et al., 1987).
Other studies have examined the relationship of platelet MAO
and HPA activities. Positive correlations have been observed
between platelet MAO and 24-hour urinary free Cortisol in unipolar
depressed patients (Agren & Oreland, 1982). In addition, it has
been observed that depressed patients with high platelet MAO
activity are more likely to be DST non-suppressors than are
patients with low platelet MAO activity (Georgotas et al . , 1986;
Hartong et al., 1985), Schatzberg et al . , 1983b; Schatzberg et
al., 1985). Reports also exist of positive correlations between
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platelet MAO activity and post-dexamethasone Cortisol levels
(Meltzer et al., 1988; Schatzberg et al
. , 1987).
Several of the studies examining the relationship between HPA
and platelet MAO activity have found that specific clinical
symptoms have been associated with both biochemical measures
studied. Schatzberg et al. (1985) found that both post-
dexamethasone Cortisol levels and platelet MAO activity were
correlated with total HRSD score (a measure of severity), and
early, middle and late insomnia. Agren & Oreland (1982) reported a
significant positive correlation between both urinary free
Cortisol, platelet MAO activity, and early morning awakening.
Finally, Georgotas et al. (1986) hypothesized that one reason that
higher MAO activity has been found in DST non-suppressors may be
that anxiety and agitation which have been found to be associated
with higher platelet MAO activity, may also "account for some
cases of DST non-suppression" (p. 265).
Studies reporting on the clinical correlates of biological
measures of depression often present discrepant findings, and
point to a complex relationship between HPA activity,
catecholamine systems, platelet MAO activity, and specific signs
and symptoms. Many of the studies are complicated by the use of
diagnostic categories, particularly the endogenous, non-endogenous
distinction. Due to the lack of a valid operational definition of
endogenous depression (Zimmerman et al., 1985), this diagnostic
subtype does not consistently identify a homogeneous group of
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patients, and has also been found to be confounded with severity
of illness ( Kumar et al
. , 1986).
Studies which organize data from biological measures of
depression around "symptoms and their severity rather than
diagnostic groups" (Davis et al
. , 1981, p. 1560) may prove to be
of more potential use clinically. Even more promising are studies
which have used either a multiple correlational approach or
discriminate function in the analysis of their data. These
approaches have allowed researchers to disregard diagnostic
labeling while simultaneously examining both endogenous and
nonendogenous symptoms. Further research is needed in the attempt
to elucidate the relationship between biological measures of
depression and their clinical correlates. Future studies must take
into consideration the effects of sex and age on biological
measures, as well as distinguish between unipolar and bipolar
depressed patients. In addition, further studies are needed to
measure several biological factors in the same group of people,
and to examine the inter-relationship between these biological
measures, as well as their association with clinical
characteristics.
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Purpose of study
The present study was conducted in order to more fully
explore the relationship between four biological measures (post-
dexamethasone Cortisol, urinary free Cortisol, urinary MHPG,
platelet MAO activity) and clinical symptoms of depression.
The majority of previous studies in which relationships
between biochemistry and clinical symptoms have been examined,
have focused on major depressive disorder without consideration of
subtypes. Most of these studies have also investigated
relationships between clinical features and biological measures in
combined groups of females and males. Despite reports of
associations between biochemical measures and age and severity,
few studies have controlled for these effects.
In this study, associations between biochemistry and
clinical symptoms were studied not only in the total group of
patients, but in a subgroup of patients diagnosed with unipolar
major depression as well. Further analyses were performed on
female and male patients separately. It was anticipated that
different relationships would be observed between biological
measures and clinical symptoms in the total group of patients as
compared to the unipolar patients, and in the female subgroups as
compared to the male subgroups. In the present study the effects
of age and severity were controlled for in order to determine
whether relationships between the biological measures and clinical
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symptoms would remain after these effects were statistically
removed
.
Previous research has primarily examined the relationship
between biological measures and endogeneity, severity, endogenous
symptoms, and/or nonendogenous symptoms. In the present study
these relationships were also examined in order to determine
whether the biological measures would relate more strongly to
overall endogeneity and severity, or more to specific symptoms of
depression. Both endogenous and nonendogenous symptoms were
studied in an attempt to determine whether endogenous or
nonendogenous symptoms would be more frequently and strongly
related to the biological measures. Based on findings from
previous reports, in the present study it was anticipated that non-
suppressors and suppressors on the DST would be able to be
distinguished from one another on the basis of clinical symptoms,
and that a "high" and "low" MHPG syndrome could be identified.
In the present study the relationship between biological
measures and suicidality was a primary focus. Much of the previous
literature which has examined this relationship has focused on
past suicidality, most often in either suicide victims or suicide
attempters. In the present study both past suicidality (occurring
during the worst week of the current episode), and current
suicidality (occurring during the same week as the biological
measurement) were studied in order to more fully explore the
relationship between suicidality and biological measures, as well
as to determine whether assessment of past or present suicidality
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affected these relationships. This study was also designed to
examine whether patients with higher ratings of suicidality would
differ biochemically from patients with lower ratings of
suicidality.
The present study is one of the few to examine relationships
between clinical symptoms and more than one biological measure. It
was designed to assess different aspects of biological functioning
(HPA activity, noradrenergic activity, platelet MAO activity)
simultaneously in the same group of patients, and to explore
whether the presence of specific clinical symptoms was related to
more than one biological measure.
This study was designed as an exploratory study with the
intention both of confirming or disconf irming previous reports, as
well as suggesting areas for further exploration of the
relationship between biological measures and clinical correlates.
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CHAPTER II
METHODS
This study included 83 patients with major depressive
disorder (52 female and 31 male) who ranged in age from 18 to 65
years (mean i SD age= 38.5 i 11.5). All patients were medically
and neurologically healthy. Any patient with marked recent weight
loss of 20% of body weight was excluded (Carroll et al., 1981).
Subjects did not receive psychoactive medication for at least
seven days (at least two weeks in the case of two patients who had
previously been on MAO inhibitors) before blood was drawn for
platelet MAO determination, with the exception of the
administration of low doses of a benzodiazepine to six patients
for agitation or insomnia. Of these, four received oxazepam, one
received lorazepam, and another flurazepam.
Informed consent was gained from all participating patients
after a complete explanation of research procedures. Clinical
ratings and biochemical measures were obtained during a one week
period. During this time period, all patients were rated using the
21-item Hamilton Rating Scale for Depression (HRSD) (Hamilton,
1960). HRSD scores ranged from 11 to 39, with a mean i S.D. of
24.2 i 5.4. Forty-three patients were interviewed using the
Schedule for Affective Disorders and Schizophrenia (SADS).
Patients were diagnosed using Research Diagnostic Criteria (RDC)
(Spitzer et al., 1978), or other available clinical data. Of the
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83, 67 met criteria for unipolar major depression. Sixteen met
criteria for bipolar disorder. Of those, 5 were bipolar I, eleven
were bipolar II. Of the 67 unipolar major depressed patients, 47
and sixteen fulfilled criteria for definite and probable
endogenous sub-types respectively. Four were not endogenous.
The presence or absence of psychotic features of depression
was rated clinically on a 3 point scale; a rating of 1 indicated
the absence of psychotic features, a rating of 2 the probable
presence of psychotic features, and a rating of 3 the definite
presence of psychotic features. Seventy-six patients received a
rating of 1, two patients received a rating of 2, and five
patients received a rating of 3.
Suicidality was assessed in two ways. Current suicidality
was rated using the HRSD suicide item (item 3), a five point scale
ranging from 0 (absence of suicidal ideation) to 4 (serious
suicide attempt). Twenty-one patients received a rating of 0,
thirty-two a rating of 1, twenty a rating of 2, and nine a rating
of 3. No patients received a rating of four, and one patient had
missing data.
Past suicidality was rated using the SADS item suicidal
tendencies (item 246), which assesses suicidality occurring during
the worst week of the current episode or during the worst week of
the past year. This item ranges from 1 (absence of suicidal
ideation) to 7 (serious suicide attempt). Eight patients received
a rating of 1, four patients a rating of 2, ten patients a rating
of 3, sixteen patients a rating of 4, and one patient each.
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ratings of 5, 6, and 7. In this study, all clinical ratings were
performed by raters who were blind to the biochemical data.
Each patient had blood samples drawn using a simple needle
stick. Blood samples were drawn between 8 a.m. and 9:30 a.m. for
determination of platelet MAO activity. When two platelet MAO
activity levels for a patient were available, mean values were
used in the data analysis. Blood was drawn for the determination
of Cortisol at 4 p.m. on days 1 and 2 of the study. A 1 mg. dose
of dexamethasone was given at 11 p.m. on day 1 of the study. All
patients had at least one MAO level drawn on a day other than that
following the administration of the dexamethasone. Sixty-seven
patients collected 24 hr. urine specimens for MHPG and UFC
determination over a two or three day period. Patients were given
detailed instructions concerning the collection of 24-hour urine
specimens; the completeness of the collection was ascertained by
careful interviews, with specific documentation and recording of
possible urine losses, and by measurements of 24-hour urine volume
and creatinine excretion. Mean values of urinary measurements were
used for data analysis.
Differential centrifugation was used to isolate the
platelets, and platelet MAO activity was determined by measuring
deamination of 12 C-tryptamine bisuccinate by methods described by
Orsulak et al. (1978) and by Gudeman et al. (1982); activity is
expressed as nanomoles tryptamine deaminated per hour per mg.
protein. On several occasions, levels of MAO activity isolated in
platelets that were obtained by this differential centrifugation
method were compared with those levels from platelets obtained
by
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the Corash procedures (Corash et al., 1977) and similar values
were observed for platelet MAO activity (Mooney et al., 1981).
Plasma Cortisol levels were determined with radioimmunoassay
(RIA) methods, as described by Schatzberg et al. (1983a). Non-
suppression was defined as a 4 p.m. post-dexamethasone Cortisol
level) 5 Hg./dl. (Carroll et al
. , 1981; Schatzberg et al
. , 1983a).
Total 24-hour urine collections were obtained with acetic
acid as preservative and aliquots were stored at -20" C until
analysed. Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) was
determined by electron capture gas chromatography using a
modification of the method of Dekirmenjian and Maas (1970). Under
routine operations, the interassay coefficient of variation was
6.2%. Urinary free Cortisol was determined by radioimmuno assay
using a commercially available (Amersham Cortisol I^^^
radioimmunoassay system) antibody specific for Cortisol and I^^^
labled antigen following the method described in the NEDH
Laboratory of Pathology Chemistry Procedure Manual. Biochemical
determinations were performed by laboratory personnel blind to the
clinical diagnosis.
Data were analyzed using the Statistical Package for the
Social Sciences (SPSS-X). Separate multiple regression analyses
were performed using each of the biochemical measures as the
dependent variable, and age and severity as the independent
variables in the analyses involving post-dexamethsone Cortisol and
platelet MAO activity, and age, severity, creatinine and total
volume of urine as independent variables in the analyses involving
urinary free Cortisol and MHPG. Standardized residuals from these
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regressions were then correlated with the items from the HRSD and
selected items from the SADS using Spearman correlations. Here
these are referred to as partial correlations. Zero-order Spearman
correlations were also calculated between the biological measures
and clinical symptoms. Only the correlations between the
biological measures and age, severity and endogeneity are
presented here.
Correlations were calculated for the following groups: the
total group of patients, the group of unipolar major patients, and
the group of bipolar patients. Correlations were also computed for
females and males separately within these diagnostic groups. Data
from the bipolar patients are not reported on here, as the small
sample size in the bipolar group, particularly in the female and
male subsets make questionable the interpretation of the results.
Correlations attaining p values of < .05 were considered
significant, however, due to the large number of correlations
computed in this study, the Bonferroni correction was applied.
Data were interpreted both with and without this correction (see
Discussion, p. 68).
Multiple regression analyses were performed after the
computation of the correlation matrices, using each of the
biochemical measues as the dependent variable, and using variables
that had been observed to be significantly correlated with the
specific biochemical measure, as well as age, sex and severity, as
independent variables. Data were also analyzed using analysis of
variance (ANOVA), covarying for age, sex and severity,
discriminant function analyses, and Chi Square.
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CHAPTER III
RESULTS
Post-dey^methasone Cortisol and clinicaT ^y^P^"""'
Table 5 lists all significant correlations between post-
dexamethasone Cortisol and clinical symptoms in the total group of
patients and in the female and male subgroups. In the total group
of patients (see Table 5, p. 43) guilt was the only endogenous
symptom to correlate significantly (negatively) with post-
dexamethasone Cortisol after controlling for the effects of age
and severity. The nonendogenous symptom somatic anxiety was also
significantly and negatively correlated with post-dexamethasone
Cortisol. The presence of psychotic symptoms, and the age of onset
of the illness, were also observed to be positively associated
with post-dexamethasone Cortisol, but age (r = -.17, p = NS) and
severity of illness (r = .20, p = .08) were not significantly
related with post-dexamethasone Cortisol in the total group of
patients. The relationship between post-dexamethasone Cortisol and
endogeneity was stronger than that observed with age and severity
(r = .21, p = .06), but was also not significant.
In the female subgroup a similar pattern of relationships
between post-dexamethasone Cortisol and clinical symptoms emerged.
In females, even stronger relationships were observed between post-
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dexamethasone Cortisol and guilt, somatic anxiety, psychosis, and
age of onset of the illness. In addition, a significant positive
correlation with endogeneity was observed in females. In the male
patients completely different associations were observed, with the
only significant correlations occurring between post-dexamethasone
Cortisol and the endogenous symptom psychomotor retardation
(positive correlation), and between post-dexamethasone Cortisol
and the nonendogenous symptom subjective anger (negative
correlation)
.
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TABLE 5
PARTIAL CORRELATIONS^ RKTWEEN PQST-nEXAMF.THA<^nMR rnPTTcny ANDCLINICAL SYMPTOMS IN THE TOTAL GROUP OF PATTFMTg
Post-dexamethasone Cortisol: All patipnts (N=83
Guilt (H)^
-.26
.02
Somatic anxiety ( H) 34 .002
Psychosis 26 .02
Age of onset of illness; (S)^ 44 .01 (N=33)
Post-dexame thasone co r t i so 1
Females (N =52) Males (N=31)
L B. L Q.
Guilt (H) 39 .005 -.03 NS
Somatic anxiety ( H) -. 38 .005 -.33 .07
Psychosis 34 .01 .03 NS
Age of onset (S) 56 .004: (N=24) .20 NS (N=9)
Endogeneity 28 .05 .08 NS
Psychomotor ret^ (S) -. 14 NS (N=24) .54 .05 (N=14)
Subjective anger (S) . 02 NS (N=25) -.68 .005 (N=15)
^ Spearman correlations (two-tailed) were computed after the
effects of age and severity on post-dexamethasone Cortisol had
been controlled for.
^ (H)= Item from Hamilton Depression Rating Scale
^ (S)= Item from Schedule for Affective Disorders and
Schizophrenia
^ ret= retardation
After Bonferroni correction, p values < .002 are significant.
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In the unipolar major group (See Table 6, p. 45), none of the
endogenous symptoms correlated with post-dexamethasone Cortisol,
after the effects of age and severity had been removed. As
observed in the total group of patients, post-dexamethasone was
again significantly and negatively correlated with somatic
anxiety, and positively correlated with the age of onset of
illness. Additionally, in the unipolar major patients the length
of the current illness was observed to be negatively associated
with post-dexamethasone Cortisol.
In both unipolar females and males, the nonendogenous
symptom somatic anxiety was negatively and significantly
associated with post-dexamethasone Cortisol. Aside from this
common finding, different patterns of relationships between post-
dexamethasone Cortisol and symptoms emerged in females and males.
In female unipolar patients the only endogenous symptom to
correlate significantly (negatively) with post-dexamethasone
Cortisol was guilt. Significant positive correlations were also
observed in female unipolars between post-dexamethasone Cortisol
and the nonendogenous symptom obsessional ity, as well as with age
of onset of the illness. In male unipolars, three different
negative significant correlations were observed between post-
dexamethasone Cortisol and the following nonendogenous items:
gastrointestinal symptoms, somatic symptoms, and subjective anger.
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TABLE 6
PARTIAL CQRRELATIQNS^ RF.TWF.EN POST-nRV&f^f;THASQNR mRTT^^ny, ftMpCLINICAL SYMPTOMS TNI UKT^OIA R mYorT^T^^^^^
^
P95t dexamethasone Cortisol: An iir^tpoiar Da<-,ii>n»«i rM=A7)
L EL
Somatic anxiety (H) -.38
.001
Age of onset (S)^ .39
.05 (N=26)
Length of illness (S) -.38 .04 (N=29)
Post-dexameth^sone corti^n)
Fgmaleg (N=42) Males (N=25)
L a La
Somatic anxiety (H) -.38 .01 -.44
.03
Age of onset (S) .49 .04 (N=19) .14 NS (N=7)
Length of illness (S) -.36 NS (N=20) -.54 NS {N=9)
Guilt (H) -.33 .03 .006 NS
Obsessional ity (H) .49 .03 (N=19) .24 NS (N=12)
Gastrointestinal symptoms . 12 NS -.39 .05
Somatic Symptoms .04 NS (N=41) -.41 .04
Subective anger (S) . 11 NS (N=21) -.58 .04 (N=13)
^ Spearman correlations (two-tailed) were computed after the
effects of age and severity on post-dexamethasone Cortisol had
been controlled for.
^ (H) = Item from Hamilton Rating Scale for Depression
^ (S) = Item from Schedule for Affective Disorders and
Schizophrenia
After Bonferroni correction, p values < .003 are significant.
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To more fully examine the relationship between clinical
symptoms and post-dexamethasone Cortisol, a multiple regression
analysis was performed on the total group of patients using forced
entry of variables. In this analysis, variables which were
observed to be significantly correlated with post-dexamethasone
Cortisol, as well as age, sex and severity, were used as the
independent variables, and post-dexamethasone Cortisol was set as
the dependent variable. This analysis identified three items (p <
.03) which accounted for a significant portion of the variance
(multiple R = .62, R square = .38, p = .001). These items were
psychosis and endogeneity which entered in a positive direction,
and guilt which entered in a negative direction.
In order to examine the clinical difference between
suppressors {N=59) and non-suppressors (N=24) of post-
dexamethasone Cortisol on the items of the HRSD, a discriminant
function analysis was performed. Only one symptom, paranoia, was a
significant contributor (p = .04) to the discriminant function
separating suppressors and non-suppressors. Patients were able to
be classified into suppressors and non-suppressors with only 51.8
% accuracy.
Post-dexamethasone Cortisol and suicide
Analysis of variance, covarying for the effects of age, sex,
and severity was used to compare the mean levels of post-
dexamethasone Cortisol in those patients with a rating of 2 or
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above on the HRSD suicide item (mean i SD post-dexamethasone
Cortisol = 3.68 i 4.12), and those patients with a HRSD suicide
rating of less than 2 (mean i post-dexamethasone Cortisol =4.11 +
4.65). No significant effects for either group (F = 1.16, p = NS)
or covariates were observed.
In those patients with HRSD suicide ratings of 2 or above,
seven were non-suppressors, and 2 were suppressors. In patients
with HRSD suicide scores of less than 2, seventeen were non-
suppressors and 36 were suppressors (Chi square = .26, df = 1, p =
NS)
.
Urinary free Cortisol (UFO and clinical symptoms
Table 7 lists all significant correlations between UFC and
clinical symptoms in the total group of patients and in the female
and male subgroups. In the total group of patients in whom urinary
free Cortisol was measured (N=38) (see Table 7, p. 49), two
endogenous symptoms, agitation and guilt, and two nonendogenous
symptoms, subjective anger and overt anger were observed to be
negatively and significantly correlated with urinary free Cortisol
after the effects of age, severity, creatinine and total volume of
urine had been controlled for. Correlations of only trend
significance were observed between UFC and age (r = .31, p = .06),
and UFC and severity (r = .28, p = .09). No significant
relationship was observed between UFC and endogeneity (r = .11, p
= NS).
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In the subgroup of females, significant negative partial
correlations were again observed between urinary free Cortisol and
the endogenous symptom agitation (as measured on both the HRSD and
SADS), but not with guilt. In contrast to findings in the total
group, in females the nonendogenous symptoms paranoia (negative
correlation), and increased sleep (positive correlation, were also
observed to be significantly associated with urinary free
Cortisol
.
In the male subgroup of patients, a different pattern was
observed. As in the total group, subjective anger was negatively
correlated with UFC, however in males the endogenous symptom
retardation was also observed to be significantly and positively
correlated.
48
TABLE 7
PARTIAL CORRELATIONS^ BETWEEN URINARV FRF.E CORTISQI. (UFO AND
CLINICAL SYMPTOMS IN THE TOTAL GROUP OF PATIENTS
Agitation (H)
Guilt (S)^
Subjective anger (S)
Overt anger (S)
TOTAL GROUP
UFC; All Patients (N=:^B)
L B.
-.60 .002
-.41 .05 (N=24)
-.60 .002 (N=24)
-.63 .009 (N=23)
UFC: Females =23) Males (N:=16)
L B. r E.
Agitation (H) -.60 .002 -.38 NS
Guilt (S) -.34 NS (N=14) -.27 NS (N= 10)
Subjective anger (S) -.41 NS (N = 13) -.84 . 001 (N =11)
Overt anger (S) -.44 NS (N= 12) -.46 NS (N=11)
Agitation (S) -.68 .06 (N =12) .31 NS (N = 10)
Paranoia (S) -.66 .03 (N =11) -.55 NS (N==10)
Retardation (H) -.06 NS .62 .02
Increased sleep (S) .69 .009 (N==13) .26 NS (N==9)
^ Spearman correlations (two-tailed) were computed after the
effects of age, severity, creatinine and total volume on UFC had
been controlled for.
^ (H)= Item from Hamilton Rating Scale for Depression
^ (S)= Item from Schedule for Affective Disorders and
Schizophrenia
After Bonferroni correction, p values < .003 are significant.
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In the unipolar major group of patients (see Table 8, p.
51), urinary free Cortisol again correlated negatively with
agitation, as well as with another endogenous symptom, psychomotor
retardation (positive correlation). In the unipolar group, the
nonendogenous symptoms of subjective and overt anger again
correlated negatively with urinary free Cortisol, and a positive
correlation with the nonendogenous symptom obsessional ity was
observed as well.
In female unipolar patients, fewer significant correlations
were observed, with only the correlation between urinary free
Cortisol and the endogenous symptom agitation attaining
significance. In the male unipolar subgroup, no significant
correlations with endogenous symptoms were seen, and the
relationships between urinary free Cortisol and nonendogenous
symptoms paralleled those of the total unipolar group; significant
partial correlations were observed between urinary free Cortisol
and subjective and overt anger, and a positive significant partial
correlation between urinary free Cortisol and obsessional ity was
observed as well.
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TABLE 8
PARTIAL CORRELATIONS^ BETWEEN URINARY FREK mPTTgnr. aKin CLINICAL
SYMPTOMS IN UNIPOLAR MAJOR PATIENTS
~
UFC; All Unipolar Patients (N=.l?.)
L
Agitation (n) 47 .007
c
UDsessionai 1 ty (S) 54 .02 (N=18)
Subjective anger (S) 65 .003 (N=19)
Overt Anger (b) 69 .002 (N=18)
Psychomotor retardation ( S) ,51 .04 (N=17)
UFQ: Females (N=19)
L
Agitation (H) -.61 .006 (N=19)
Obsessional ity (S) .11 NS (N=10)
Subjective anger (S) -.28 NS (N=10)
Overt anger (S) -.61 .08 (N=9)
Psychomotor retardation (S) .42 NS (N=9)
Males (N=13)
-.26 NS (N=13)
.96 .00 (N=8)
-.77 .02 (N=9)
-.73 .03 (N=9)
.40 NS (N=8)
^ Spearman correlations (two-tailed) were computed after the
effects of age, severity, creatinine and total volume on UFC had
been controlled for.
^ (H) = Item from Hamilton Rating Scale for Depression
^ (S) = Item from Schedule for Affective Disorders and
Schizophrenia
After Bonferroni correction, p values < .003 are significant.
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A multiple regresssion analysis using forced entry of
variables was performed in the total group of patients in order to
further explore the relationship bewteen urinary free Cortisol and
clinical symptoms. In this analysis the dependent variable was
urinary free Cortisol, and the independent variables were those
that had been observed to be significantly correlated with urinary
free Cortisol, as well as age, sex, severity, and suicidal
tendencies. Suicidal tendencies was entered as an independent
variable based on previous findings suggesting that past
suicidal ity may play a part in explaining the total variance of
UFC. Overt anger, and subjective anger were significant negative
contributors, and suicidal tendencies, and severity were
significant positive contributors to the variance of urinary free
Cortisol (p < .05) (multiple R= .63, R square = .40, p = .0006).
Urinary free Cortisol and suicide
An analysis of variance covarying for the effects of age, sex
and severity was used to compare the mean levels of urinary free
Cortisol in those patients in the total group with a HRSD rating
of 2 or above (mean + SD urinary free Cortisol = 105.66 i 44.49),
and those patients with a HRSD suicide rating of less than 2 (mean
i SD urinary free Cortisol = 97.48 i 31.94). Significant effects
for age (F= 4.43, p = .04), sex (F= 7.96, p = .008), and severity
(F = 4.31, p = .05) were observed, however, the main effect for
group was non-significant (F= .05), P = NS).
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MHPG (3-methoxY-4-hvdroxvphenvlqlvcQn ^nH rlinical svmnl-nm^
In the total group of patients (see Table 9, p. 54) for whom
values for MHPG, creatinine and total urinary volume were
available (N=64), only the nonendogenous symptom depressed mood
correlated significantly and negatively with MHPG after the
effects of age, severity, creatinine and total volume on MHPG had
been controlled for. Neither age (r= .13, p = NS), severity (r =
.11, p = NS) nor endogeneity (r = -.02, p = NS) were significantly
correlated with MHPG in the total group. In the female and male
subgroups, again only nonendogenous symptoms were observed to
correlate significantly with MHPG, with paranoia correlating
positively with MHPG in females, and somatic symptoms correlating
positively in males.
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TABLE 9
PARTIAL CORRELATIONS^ BETWEEN 3-METH0XY-4-HYDRQXYPHF.NVr.rj.vrnT.
(MHPG) AND CLINICAL SYMPTOMS IN THE TOTAT. HRQUP qf PATTRMT.q
TOTAL GROUP
MHPG: All Patients (N=f;4)
L El
Depressed Mood (H)*^ -.26 .04
MHPG; Females (N=42) Males (N=22)
L E. L E
Depressed mood (H) -.22 NS -.33 NS
Paranoia (H) .31 .05 -.31 NS
Somatic symptoms (H) -.05 NS (N=41) .46 .03
^ Spearman correlations (two-tailed) were computed after the
effects of age, severity, creatinine and total volume on MHPG had
been controlled for.
I-
(H) = Item from Hamilton Rating Scale for Depression
After Bonferroni correction, p values < .007 are significant.
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In the unipolar major group (see Table 10, p. 56) the only
endogenous symptom to correlate significantly (positively) with
MHPG was agitation, and the only nonendogenous symptom to
correlate was obsessional ity
.
In the female subgroup, correlations
with agitation and obsessional ity were nonsignificant, however in
females MHPG correlated significantly with three other
nonendogenous symptoms: depressed mood (negative correlation),
paranoia, and number of suicide attempts (positive correlations).
In the male unipolar patients only the correlation between the
endogenous symptom agitation and MHPG attained statistical
significance.
In a multiple regression analysis performed on the total
group of patients, in which MHPG was dependent and variables which
had attained significance in the correlation analyses, as well as
age, sex, and severity were the independent varables, sex,
agitation and obsessionality were found to contribute
significantly in a positive direction (p < .05) to the variance of
MHPG (multiple R = .57, R square = .32, p = .0005). These findings
did not appear to be due to an interaction effect of sex with
agitation and obsessionality, as sex was not significantly
correlated with either agitation (r = .01, p = NS) or
obsessionality (r = .06, p = NS).
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TABLE 10
PARTIAL CORRELATIONS^ BETWEEN MHPG AND aJNTra r. SYMPTOMS IN
UNIPOLAR MAJOR PATIENTS '
'
MHPG: All Unipolar Patients (N=K7)
Obsessionality (H)*^ .28 .05 (N=53)
Agitation (S)^
.44 .01 (N=30)
MHPG: Females (N=42) Males (N = 25)
r r Bl
Obsessionality (H) .21 NS (N=35) .34 NS (N=18)
Agitation (S) .28 NS (N=20) .77 .009 (N=10)
Depressed mood (H) .33 .05 (N=36) -.10 NS (N=18)
Number suicide attempts .49 .04 (N=18) .00 NS (N=7)
Paranoia (S) .53 .04 (N=15) -.40 NS (N=9)
Spearman correlations (two-tailed) were computed after the
effects of age, severity, creatinine and total volume on MHPG had
been controlled for.
(H) = Item from Hamilton Rating Scale for Depression
^ (S) = Item from Schedule for Affective Disorders and
Schizophrenia
After Bonferroni correction, p values < .004 are significant.
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MHPG and suicid^
A discriminant function analysis using variables which had
been observed to be significantly correlated with MHPG in zero-
order correlations, was performed in the total group in order to
determine whether patients with "high" levels of MHPG (using a
median split) could be separated from those with "low" MHPG on the
basis of clinical symptoms. Only one symptom, suicidal tendencies
(as rated on the SADS) was a significant contributor (p = .005) to
the discriminant function separating patients with "high" MHPG
from those with "low" MHPG. Patients were able to be classified
into" high" and "low" MHPG groups with 64.1 % accuracy.
An analysis of variance covarying for the effects of age,
sex, and severity was used to compare mean levels of MHPG in the
subgroup of patients with a score of 3 and above on the SADS item
suicidal tendencies (N= 27) (mean + SD MHPG = 2585.11 i 1089.74)
to those with a score of less than 3 on the SADS item suicidal
tendencies (N = 12) (mean ± SD MHPG = 2087.33 i 632.12). A
significant effect for sex (F= 24.35, p = .000) was observed,
however a main effect for group did not attain significance (F =
.24, P = NS).
In the total group of patients, a similar analysis of
variance, covarying for age, sex and severity was performed.
Patients with a HRSD suicide rating of 2 and above (mean i SD MHPG
+ 2282 + 718.64) were compared to those with a HRSD suicide rating
of less than 2 (mean ± SD MHPG = 2496.28 i 1001.79). Again, a
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significant effect for sex (F = 32.22, p = .000) was observed, as
well as a significant effect for severity (F = 7.89, p = .007). A
significant main effect on MHPG was not observed (F= 1.15, p =
NS).
Platelet monoamine oxidase (MAO) ^rt ivity ;.nH M.inic;^i
..yn^pi-nnx.
In the total group of patients (See Table 11, p. 60),
platelet MAO activity was not significantly correlated with any
endogenous symptoms after the effects of age and severity on
platelet MAO activity had been controlled for. Platelet MAO
activity was also not observed to correlate significantly with
either age (r = .009, p = NS), or severity (r = .08, p = NS), and
although correlated more strongly with endogeneity (r = .21, p =
.06), this correlation did not attain statistical significance.
Significant partial correlations were observed between platelet
MAO activity and the nonendogenous symptoms of suicide (positive
correlation), somatic anxiety, somatic symptoms, and genital
symptoms (negative correlations).
In the female subgroup a similar pattern was seen, with
platelet MAO activity again correlating with the nonendogenous
symptoms suicide, somatic anxiety, somatic symptoms, and in
addition correlating with obsessionality (positively). In females
the correlation between platelet MAO activity and genital symptoms
did not attain significance. Although no significant association
between platelet MAO activity and specific endogenous symptoms
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were observed, overall endogeneity was significantly and
positively correlated with MAO in females. In males, somatii
anxiety was again observed to be negatively correlated with
platelet MAO activity, and a negative correlation with para
was observed as well.
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TABLE 11
PARTIAL CORRELftTIONS^ RETWEEN PLATELET MONOAMTMP nvTnacF ACTIVITY
AND CLINICAL SYMPTOMS IN THE TOTAL GROUP OF PATTRNT<^
TOTAL GROUP
Platelet MAO ; All oatienhs (N=ftT)
Suicide (H)*^ .26 .02
Somatic anxiety (H) -.32 .003
Somatic symtoms (H) -.27 .02
Genital symptoms (H) -.22 .05
Platelet MAO: Females (N=62) Males (N=31)
r Q. r BL
Suicide (H) .32 02 (N=51) .02 NS
Somatic anxiety (H) -.27 05 -.65 .001
Somatic symptoms (H) -.30 03 -.21 NS
Genital symptoms (H) -.27 06 -.12 NS
Endogeneity .30 03 .04 NS
Obsessionality (H) .45 001 (N=51) -.21 NS
Paranoia (S) .09 NS (N=18) -.70 .01 (N=12)
^ Spearman correlations (two-tailed) were computed after the
effects of age and severity on platelet MAO activity had been
controlled for.
^ (H) = Item from Hamilton Rating Scale for Depression
^ (S)= Item from Schedule for Affective Disorders and
Schizophrenia
After Bonferroni correction, p values < .003 are significant.
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In the unipolar major group (see Table 12, p. 63) platelet
MAO activity correlated significantly with overall endogeneity,
however no relationship with specific endogenous symptoms was
observed. As in the total group, platelet MAO activity correlated
significantly with the nonendogenous symptoms of suicide (positive
correlation), somatic anxiety, and somatic symptoms (negative
correlations). In addition, a negative correlation with paranoia
was observed.
In the female and male subgroups (see Table 13, p. 64), no
endogenous symptoms were significantly associated with platelet
MAO activity. In females only, overall endogeneity was observed to
be significantly correlated with platelet MAO activity. The
pattern of relationships between nonendogenous symptoms and
platelet MAO activity was completely different in female and male
patients. In the female subgroup, platelet MAO correlated
significantly with suicide, psychic anxiety, obsessional ity
(positive correlations), somatic symptoms and genital symptoms
(negative correlations). In males, none of theses symptoms were
significantly related to platelet MAO activity. Instead,
significant negative correlations were observed between platelet
MAO activity and somatic anxiety, paranoia and depressed mood.
A multiple regression analysis was performed on the total
group of patients to further examine the relationship between
platelet MAO activity and clinical symptoms. In this analysis,
platelet MAO activity was the dependent variable, and the
independent variables (those which had attained statistical
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significance in the correlational analyses as well as age, sex and
severity), were forced into the equation. Five variables accounted
for a significant portion of the variance (p < .05) (multiple R =
.66, R square = .43, p = .0000). Sex, somatic anxiety and somatic
symptoms entered negatively, and severity and current suicidality
(HRSD), entered positively.
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TABLE 12
PARTIAL CORRELATIONS^ BETWEEN PLATF.T.ET MQNnRMTMF nvTn^Qp ACTIVITY
AND CLINICAL SYMPTOMS IN UNIPOLAR MAJOR PftTTRM?^
Platelet MAO: All Unipolar Patients (M=f;7)
L EL
Endogeneity
.26 .03
Suicide (H)*^ .36 .003 (N=66)
Somatic anxiety (H) -.27 .03
Somatic symptoms (H) -.30 .02 (N=66)
Paranoia (S) -.40 .06 (N=25)
Spearman correlations (two-tailed) were computed after the
effects of age and severity on platelet MAO activity had been
controlled for.
^ (H) = Item from Hamilton Rating Scale for Depression
^ (S) = Item from Schedule for Affective Disorders and
Schizophrenia
After Bonferroni correction, p values < .002 are significant.
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TABLE 13
(MAO) AND CLINICAL SYMPTOMS IN UNIPOLAR MA.inp
NE OXIDA
FEMALES
SE ACTIVITY
AND MALES
UNIPOLAR MAJOR GROUP
Platelet MAO
Females (N=42) Males (N=25)
r & r EL
Endogeneity
. u
.15 NS
Suicide (H)*^
.35 .03 (N=41)
.24 NS
Somatic anxiety (H) -.24 NS
-.53
.007
Somatic symptoms (H) -.33 .04 (N=41) -.18 NS
Paranoia (S) -.11 NS (N=15) -.85
.002 (N=10)
Psychic anxiety (H) .38 .01 -.36
.08
Genital symptoms (H) -.33 .04 (N=39) -.02 NS (N=23)
Obsessional ity (H) .49 .001 (N=41) -.16 NS
Depressed mood (H) .14 NS -.45 .02
Spearman correlations (two-tailed) were computed after the
effects of age and severity on platelet MAO activity were
controlled for.
(H) = item from Hamilton Rating Scale for Depression
(S) = Item from Schedule for Affective Disorders and
Schizophrenia
After Bonferroni correction, p values < .002 are significant.
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Platelet MAO and snirir^o
Analysis of variance, covarying for the effects of age, sex
and severity was used to compare the mean levels of platelet MAO
activity in those patients in the total group with a HRSD rating
of 2 or above (mean ± SD MAO = 8.27 ± 2.77 nanomoles of tryptamine
deaminated per hour per mg of protein), and those patients with a
HRSD suicide rating of less than 2 (mean + SD MAO =6.67 + 2.43
units). Significant main effects on platelet MAO activity were
observed for group (F = 5.52, p = .02), and for sex (F = 8.32, p =
.005).
Analysis of variance, covarying for the effects of age, sex,
and severity was also used to examine levels of platelet MAO
activity in the subgroup of patients for whom ratings on the SADS
item suicidal tendencies were available (N= 41). Higher levels of
platelet MAO activity were observed in those patients with ratings
of 3 or above on the item suicidal tendencies (mean i SD MAO =
6.91 ± 2.15), as compared to patients with ratings of less than 3
on the suicidal tendencies item (mean + SD MAO = 6.53 + 2.02). No
significant effects for either covariates or group (F = .46, p =
NS) were observed however.
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Ii>ter-relationsb1 p of post-dexamethasnnp rprtisol. p l atelet MAP
activity and clinical ?vmptnf|)5^
In the total group of patients, post-dexamethasone Cortisol
was significantly correlated with platelet MAO activity (r = .28,
p = .01) (Spearman correlation, two-tailed). These two biochemical
measures correlated similarly with a number of specific clinical
symptoms.
In the total group of patients, significant negative
correlations were observed between somatic anxiety and both post-
dexamethasone Cortisol and platelet MAO activity. In addition,
both post-dexamethsone Cortisol and platelet MAO activity were
correlated similarly with overall endogeneity (r= .21, p = .06).
In the subgroup of females, somatic anxiety was once more
correlated with both biochemical measures. In addition,
endogeneity was observed to be positively and significantly
correlated with both post-dexamethasone Cortisol and platelet MAO
activity in females. In the male subgroup, there were no common
significant correlations between both biochemical measures and
specific clinical symptoms.
In the total group of unipolar patients, somatic anxiety was
again observed to be negatively correlated with both post-
dexamethasone Cortisol and platelet MAO activity. A similar
finding was observed in the male unipolar subgroup, however in the
female unipolar patients, the only symptom signicantly related to
both biochemicals was obsess ionality.
66
In the total group of patients, MHPG was significantly
correlated with UFC (r = .47, p = .003) (N = 38) (Spearman
correlation, two-tailed). Despite the association of these two
biochemicals, few clinical symptoms were observed to be
significantly correlated with both. In both the total group of
patients and in the subgroup of males, there were no similar
significant correlations. In the subgroup of female patients,
paranoia was significantly correlated with both biochemicals,
however a positive correlation was observed between MHPG and
paranoia, while UFC was negatively correlated with paranoia.
In the total group of unipolar patients, obsessional ity was
positively correlated with both MHPG and UFC. Agitation was
significantly correlated with both biochemicals, however once
again, a significant positive relationship between MHPG and
agitation was observed, while UFC was negatively correlated with
agitatiton. In neither the female or male subgroups were clinical
symptoms observed to be significantly correlated with both MHPG
and UFC.
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CHAPTER IV
DISCUSSION
Data in this study point to complex relationships between
post-dexaraethasone Cortisol, urinary free Cortisol, MHPG, platelet
MAO activity and clinical correlates. Several general patterns did
emerge, however. Overall, stronger relationships were observed
between the biological measures and specific clinical symptoms
than with either endogeneity or severity of illness. A greater
number of significant correlations were observed between the
biological measures and nonendogenous symptoms of depression, than
with endogenous symptoms. In general, different patterns of
correlations were observed in the total group of patients as
compared to the unipolar patients, and in the female subgroup as
compared to the male subgroup. Sex differences observed in this
study must be interpreted with caution however, as the sample was
predominately female, and the relatively small sample size in the
male subgroup may have contributed to the fewer significant
correlations observed in males.
Relationships between post-dexamethasone Cortisol and endogeneity,
psychosis, and severity
In this study, endogeneity was found to be significantly
(positively) correlated with post-dexamethasone Cortisol in female
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patients only. Although endogeneity was one of three significant
contributors to the total variance of post-dexamethasone Cortisol,
the correlation between endogeneity and post-dexamethasone
Cortisol in the total group did not attain statistical
significance. Overall these data suggest a significant yet weak
relationship between post-dexamethasone Cortisol and endogeneity.
While many studies have reported higher rates of DST non-
suppression in endogenously depressed patients (Coryell et al.,
1982; Feinberg & Carroll, 1984; Zimmerman et al
. , 1985; Zimmerman
et al., 1986; Zhou et al
. , 1987), few studies have examined
correlations between endogeneity and post-dexamethasone Cortisol.
One of the few studies to do so (Kumar et al
. , 1986), reported a
moderate yet significant correlation between endogeneity and post-
dexamethasone Cortisol (r = .27, p = .02), a finding consistent
with that of the present study.
In this study, post-dexamethasone Cortisol was found to be
more strongly related to endogeneity in female patients. While
previous studies have reported no sex effect on DST results (Asnis
et al., 1982; Brown & Shuey, 1980; Carroll et al., 1981; Maes et
al., 1986), none of these have examined the relationship between
endogeneity and post-dexamethasone Cortisol levels separately in
females and males.
Data in this study point to a significant relationship
between post-dexamethasone Cortisol and psychosis. Psychosis was
found to be positively correlated with post-dexamethasone Cortisol
in both the total group of patients and in the subgroup of
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females. In addition, psychosis was observed to be one of three
significant variables to contribute significantly to the total
variance of post-dexamethasone Cortisol. These findings are
consistent with other reports of high levels of post-dexamethasone
Cortisol in psychotic patients (Rothschild et al., 1987).
In the current study, the relationship between post-
dexamethasone Cortisol and severity of illness attained only trend
significance. This finding is consistent with other reports of a
lack of association between post-dexamethasone Cortisol and
severity (Berger et al
. , 1982; Brown & Shuey, 1980; Larsen et al
.
,
1985), but is in contrast with an even greater number of reports
finding severity to be positively associated with post-
dexamethasone Cortisol (Davis et al
. , 1981; Kumar et al
. , 1986;
Maes et al., 1986; Zhou et al., 1987).
Overall, post-dexamethasone was observed to be weakly but
significantly related to endogeneity, strongly related to
psychosis, and only very slightly related to severity. Based on
the results of the regression analysis, it was anticipated that
endogeneity, psychosis and guilt would be more strongly related to
post-dexamethasone Cortisol than other clinical signs and
symptoms, however this did not prove to be the case.
Post-dexamethasone Cortisol and endogenous symptoms
Many studies have reported an association between post-
dexamethasone Cortisol and specific endogenous symptoms of
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depression (Asnis et al
. , 1982; Christensen et al., 1986; Reus,
1982; Rubin et al., 1985). In the present study however, very few
significant relationships between post-dexamethasone Cortisol and
endogenous symptoms were observed. This finding is consistent with
our observation of a weak relationship between overall endogeneity
and post-dexamethasone Cortisol.
In this study, guilt was the only endogenous symptom to be
correlated (negatively) with post-dexamethasone Cortisol in the
total group of patients; this relationship was observed to be even
stronger in female patients. These findings are in contrast to
previous studies reporting a positive relationship between guilt
and post-dexamethasone Cortisol (Christensen et al., 1986; Reus,
1982; Schatzberg et al
.
, 1987).
Psychomotor retardation, another endogenous symptom of
depression, was also found to be significantly (positively)
associated with post-dexamethasone Cortisol in the present study,
however this relationship attained statistical significance in
only the subgroup of males. This finding is consistent with other
reports of a significant positive relationship between post-
dexamethasone Cortisol and retardation (Agren & Wide, 1982;
Schatzberg et al., 1987; Zimmerman et al . , 1986), however in these
studies, post-dexamethasone Cortisol and retardation were observed
to be significantly related in combined groups of females and
males, rather than in males only.
Given the relatively small number of endogenous symptoms
observed to be significantly correlated with post-dexamethasone
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Cortisol, the findings from this study can be viewed as consistent
with reports of an overall lack of relationship between post-
dexamethasone Cortisol and specific endogenous symptoms (Asnis et
al., 1982; Brown & Quails, 1981; Grunhaus et al
.
, 1985: Kaspar &
Beckman, 1983).
Post-dexamethasone Cortisol and nonendogenous symptoms
In this study, although stronger and more numerous
correlations were observed between post-dexamethasone Cortisol and
nonendogenous symptoms of depression, these correlations were
generally in a negative direction. The observation of very few
significant positive correlations between post-dexamethasone
Cortisol and nonendogenous symptoms is similar to the finding of
few positive relationships between post-dexamethasone Cortisol and
endogenous symptoms, and suggests that lower rather than higher
levels of post-dexamethasone Cortisol may be associated with the
presence of specific clinical symptoms of depression.
Of the nonendogenous symptoms to correlate significantly
with post-dexamethasone Cortisol, somatic anxiety was the most
strongly correlated, with significant negative relationships
appearing in all of the patient groups, with the exception of the
total male subgroup. This finding is in contrast to previous
reports which have found a positive association between anxiety
and post-dexamethasone Cortisol (Ceulemans et al., 1985;
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Christensen et al., 1986; Reus, 1982). These studies however, have
not reported specifically on somatic anxiety, nor have they
examined post-dexamethasone Cortisol /anxiety relationships in
specific subgroups.
Two other symptoms related to somatic disturbance, somatic
symptoms, and gastrointestinal symptoms, were found to be
negatively correlated with post-dexamethasone Cortisol in the
group of male unipolar patients. These findings are in contrast to
a previous report of Christensen et al. (1986), in which ratings
on the HRSD items somatic symptoms and gastrointesinal symptoms
were combined into one score and found to be positively correlated
with post-dexamethasone Cortisol. Differences between the
Christensen et al. study and the present one may be due both to
gender differences, as well as to the unipolar diagnosis, since in
the current study, positive yet insignificant relationships
between both somatic symptoms and gastrointestinal symptoms were
observed in the unipolar female group, while no significant
relationship was observed bewteen these symptoms and post-
dexamethasone Cortisol in the total group of patients.
In this study, the nonendogenous symptoms obsessional ity and
subjective anger were also found to be significantly related to
post-dexamethasone Cortisol. These correlations were significant
in only the unipolar female and male subgroups respectively, and
may reflect chance findings, as few reports of relationships
between these symptoms and post-dexamethasone Cortisol exist in
the literature. Schatzberg et al. (1987) did report finding a
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significant correlation between post-dexamethasone Cortisol and
obsessionality, however, this association was in a negative
direction while in the current study a positive correlation was
observed.
Two other features of depressive disorder, the age of onset
of the illness, and the length of the illness were found to be
significantly related to post-dexamethasone Cortisol in this
study. The positive association between the age of onset of
illness and post-dexamethasone Cortisol, observed in the total
group of patients and the unipolar patients, with stronger
relationships in females, has not previously been reported. It is
an intriguing finding however, as it suggests that age of onset
may play a role in the biological expression of the disorder.
The other significant finding, that of a negative
correlation between the length of the illness and post-
dexamethasone Cortisol in the group of unipolar patients, confirms
a finding of Sashidharan et al. (1984), in which it was found that
non-suppressors of post-dexamethasone Cortisol at the time of
study had been ill for shorter periods of time. This finding, in
conjunction with that of the current study, suggests that higher
levels of post-dexamethasone Cortisol may be associated with a
more acute form of the illness.
Post-dexamethasone Cortisol and discriminant function analvses
In the current study an attempt was made to replicate the
findings of Nasr et al. (1983) in which a discriminant function
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analysis was conducted using all the items from the HRSD in order
to separate suppressors from non-suppressors on the DST on the
basis of clinical symptoms. While Nasr et al. (1983) reported
being able to discriminate suppressors from non-suppressors with
92.5% accuracy on the basis of 9 clinical symptoms, in the current
study only paranoia (a variable not reported to contribute to the
discriminant function in the study of Nasr et al.), discriminated
between suppressors and non-suppressors, classifying patients with
only 51.8 % accuracy.
The finding of the present study also failed to confirm the
report of Zimmerman et al. (1985), in which successful
discrimination between suppressors and non-suppressors was made on
the basis of five endogenous symptoms.
Differences between the present study and those of Nasr et
al. ( 1983) and Zimmerman et al. ( 1986), may be due to differences
in sample size, as the current study used twice as large a sample
as the Nasr et al. (1983) study, and was approximately one-third
the size of the Zimmerman et al. ( 1986) study. In addition, the
inclusion of patients with psychotic features in the current study
may have confounded the results. An interaction effect between
paranoia and psychosis, which in this study were observed to be
significantly correlated (r = .27, p = .01), may have contributed
to paranoia being the only discriminating variable between
suppressors and non-suppressors, particularly since psychosis was
previously observed to be positively related to post-dexamethasone
Cortisol in this study.
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Post-dexamethasone Cortisol ant^ «;nif-^/io
In this study no difference in degree of suicidal ity was
found between supressors and non-suppressors of post-dexamethasone
Cortisol, or between patients with either "high" or "low" ratings
of current suicidality as measured on the HRSD. In addition, post-
dexamethasone Cortisol was not observed to be correlated with
suicide in either the total group or in any of the subgroups of
patients
.
This finding is consistent with other reports which failed
to find a relationship between the DST and suicide (Brown et al.,
1986; Secunda et al., 1986; Zimmerman et al., 1986), but is in
contrast to those which have reported a positive association
(Banki et al., 1884; Coryell & Schlesser, 1981; Reus, 1982). In
the current study, although a continuum of suicidality was
examined, few patients were severely suicidal at the time of
study, a factor which may have affected the results. In general,
it appears that in this study, suicidality was unrelated to HPA
dysregulation.
Urinary free Cortisol (UFO and clinical symptoms
Data in this study point to a stronger relationship between
UFC and specific clinical symptoms than between UFC and either
endogeneity or overall severity. Although severity was one of the
four significant contributing variables to the variance of UFC,
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the correlation between UFC and severity did not attain
significance.
Of the endogenous symptoms to correlate significantly with
UFC, agitation was observed to be the most strongly and most
frequently associated. This negative relationship between UFC and
agitation was observed in both the total and unipolar groups of
patients, however when the sexes were examined separately,
significant correlations were observed only in females. The
finding of a sex difference in UFC/agitation relationships may be
partially an artifact due to the predominance of females in this
sample.
Retardation, another measure of psychomotor disturbance, was
found to be positively and significantly correlated with UFC in
the unipolar group and in the total subgroup of males. This
observation of a positive relationship between UFC and
retardation, and a negative relationship between UFC and
agitation, suggests that retardation and agitation may be opposite
manifestations of a common underlying psychomotor disturbance,
which is in turn related to UFC.
While no other reports of associations between psychomotor
disturbance and UFC exist in the literature, several studies of
post-dexamethasone Cortisol, another measure of HPA dysfunction,
have reported positive associations with either agitation or
retardation (Agren & Wide, 1982; Asnis et al., 1982; Zimmerman et
al., 1986).
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In the current study, the endogenous symptom guilt was also
found to be negatively correlated with UFC in the total group of
patients. Again, this finding has not been reported in the
literature, however, it is consistent with our previous finding of
a negative relationship between post-dexamethasone Cortisol and
guilt.
Of the nonendogenous symptoms to correlate significantly
with UFC (subjective anger, overt anger, paranoia, increased
sleep, and obsessionality ) , only the relationships between
subjective and overt anger and UFC have been reported in the
literature. Further studies are needed to determine whether the
significant relationships observed in the present study between
UFC and paranoia, increased sleep and obsessionality are simply
random findings.
In this study, negative correlations were observed between
UFC and both subjective and overt anger as measured on the SADS.
These relationships were observed in both the total group of
patients and in the unipolar group, but were strongest in males.
This finding is consistent with a previous report of Agren & Wide
(1982) in which significant negative correlations between anger
scores on the SADS and UFC were observed.
Both the present study and the study of Agren & Wide (1982)
also point to a relationship between anger, UFC, and suicidal ity.
Agren & Wide (1982) found that seriousness plus medical lethality
of worst ever suicide attempt, subjective anger, and overt anger
(contributing in a negative direction) explained 20% of the
78
variance of UFC. In the present study, subjective anger and overt
anger were also found to contribute negatively to the variance of
UFC, however suicidal tendencies and severity contributed in a
positive direction, with all four items explaining 40% of the
total variance of UFC.
In contrast to the study of Agren & Wide (1982) in which UFC
was associated with less suicide proneness and less anger, in the
present study, UFC was associated with less anger, but greater
suicidal ity. Differences between the two studies may partly be
accounted for by the differing measures of suicidality. Agren &
Wide's finding related to the worst ever suicide attempts, while
in the present study, suicidal ideation occurring during the worst
week of the current episode was measured by the SADS item suicidal
tendencies.
The finding of a negative relationship between UFC and both
subjective and overt anger, and a positive association with
suicidality, suggests that patients who experience or display less
anger may be more likely to have higher UFC levels and may be more
suicidal as well. In this study however, we were unble to find
significant differences in levels of UFC between patients with
either "high" or "low ratings of current suicidality as measured
on the HRSD.
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In this study no significant relationship was observed
between MHPG and endogeneity. While few studies have reported on
the relationship between endogenous status and MHPG, one study
(Nelson & Charney, 1981) suggested that decreased MHPG may be
specific to endogenous depression. The results of the present
study failed to support this hypothesis.
Severity of illness was also found to be unrelated to MHPG
in the current study. This finding is consistent with many other
reports of a lack of an association between severity and MHPG
(Davis et al,, 1981; Redmond et al., 1986; Roy et al., 1986).
In this study, the only endogenous symptom to correlate with
MHPG was agitation. This correlation attained significance in the
unipolar group of patients only, and was considerably stronger in
males. Agitation was also observed to be one of three variables
to contribute significantly to the total variance of MHPG. A
significant relationship between agitation and MHPG has not
previously been reported in the literature to our knowledge,
however another symptom of psychomotor disturbance, retardation,
has been found to be positively associated with MHPG (Redmond et
al., 1986). It is possible that overall psychomotor disturbance is
related to higher levels of MHPG, and that in unipolar patients,
particularly males, this is expressed in the form of agitation,
while in other diagnostic groups or in females, it is expressed as
retardation.
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The significant correlations between MHPG and nonendogenous
symptoms (depressed mood, paranoia, somatic symptoms and
obsessionality) were relatively weak, and generally differed from
the nonendogenous symptoms reported to be significantly related to
MHPG in the literature. Only the item somatic symptoms which in
the current study was observed to be positively and significantly
correlated with MHPG in males, has been discussed in previous
reports. Redmond et al. (1986) found that depressed patients with
increased somatization had higher levels of CSF MHPG, and Agren
(1980) found that "somatic preoccupation" was one of four symptoms
to characterize a "high" MHPG group. Further studies are needed in
order to determine whether the findings in the current study
relating the nonendogenous symptoms of depressed mood, paranoia,
and obsessionality to MHPG can be replicated, or are due more to
chance findings.
MHPG and suicide
In this study relationships between MHPG and suicide
differed, depending upon whether ratings of past or present
suicidal ity was assessed (SADS vs. HRSD), and the statistical
method used. Using ANOVA, higher levels of MHPG were observed in
those patients with greater past suicidal ity (measured on the SADS
item suicidal tendencies), as compared to patients with lower
levels of past suicidality, however these differences were not
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statistically significant. In contrast, the SADS item suicidal
tendencies was found to discriminate significantly between a
"high" and "low" MHPG group, with the "high" MHPG group associated
with greater past suicidality.
Agren (1980) also using discriminant function analysis,
found the SADS item suicidal tendencies to be one of six
discriminating variables differentiating between patients with
high and low MHPG. In his study, however, Agren found MHPG to be
negatively associated with suicidal tendencies, while in the
present study MHPG was positively yet insignificantly related to
MHPG.
In contrast to the finding of a positive association between
MHPG and past suicidality using the SADS, a negative non-
significant relationship was observed between MHPG and HRSD
ratings of suicidality occurring at the time of biochemical
measurement. Lower levels of MHPG were observed in patients with
higher ratings of current suicidality (measured by the HRSD
suicide item), as compared to patients with lower ratings of
current suicidality. Again, these differences did not attain
statistical significance. The finding of a negative relationship
between MHPG and suicidality is consistent with the previously
mentioned report of Agren (1980), as well as with a report of
Secunda et al. (1986) in which suicide attempters were found to
have significantly lower urinary and plasma MHPG levels than
patients who had never attempted suicide. In the present study
however, only ratings of suicidality occurring at the time of
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biochemical measurement were negatively related to MHPG, while in
the reports of Agren (1980) and Secunda et al. (1986), ratings of
past suicidality were negatively associated with MHPG.
The findings of the current study point to the
methodological difficulties involved in studying suicide, and
suggest that some of the discrepancies in reports of relationships
between suicidality and MHPG may be due to differences in methods
of assessment of suicidality.
Relationships between platelet MAO activitv and endoaeneity
and severity
In this study, a significant positive relationship was
observed between platelet MAO activity and endogeneity in the
total group of unipolar patients. Uhen data from females and males
were analyzed separately however, this association was significant
in females only, with significant positive relationships observed
in both the total and unipolar female subgroups. This data
suggests that the association between platelet MAO activity and
endogeneity is affected both by gender and diagnosis.
Previous reports have found platelet MAO activity to be
higher in women (Bridge et al., 1985; Mann, 1979; White et al.,
1983), a finding which may partially account for our observation
of a stronger association between endogeneity and platelet MAO
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activity in females. In addition, the finding of a positive
association between platelet MAO activity and endogeneity in
unipolar patients only, is consistent with a study of Samson et
al. (1985) in which higher platelet MAO activity was reported in
unipolar endogenously depressed patients compared to bipolar
endogenous patients or unipolar nonendogenous patients.
In contrast to several reports (Gudeman et al., 1982; Mann,
1979; Samson et al., 1985), in the current study no significant
correlation was observed between platelet MAO activity and
severity of the illness. Severity of illness was however, one of
five variables to contribute significantly to the total variance
of platelet MAO activity, which suggests that perhaps an
interaction effect between severity and other clinical symptoms
exists. This study included four patients who were only mildly
depressed (total HRSD score less than 18), which may have
contributed to the lack of significant association between
platelet MAO activity and severity.
Platelet MAO activity and clinical symptoms
In this study, no endogenous symptoms of depression were
observed to correlate significantly with platelet MAO activity.
This finding is unexpected given the previously observed
significant relationship between platelet MAO activity and overall
endogeneity. The present finding is in contrast to previous
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reports which have found a negative association between MAO
activity and the endogenous symptom guilt (Perris et al., 1980;
Perris et al., 1984; Schalling et al., 1980), and positive
associations between platelet MAO activity and various forms of
sleep disturbance (Agren & Oreland, 1982; Schatzberg et al.,
1985).
In this study, several significant relationships between
platelet MAO activity and nonendogenous symptoms were observed. Of
these, somatic anxiety was the roost strongly correlated, with
significant correlations observed between platelet MAO activity
and somatic anxiety in all the patient groups with the exception
of the subgroup of unipolar females. This finding is in direct
contrast to studies by Davidson et al. (1980) in which a positive
association was observed between platelet MAO activity and
anxiety, and Georgotas et al. (1986) in which platelet MAO
activity was found to be positively correlated with somatic
anxiety. In the study of Georgotas et al., psychic anxiety was
found not to relate significantly to platelet MAO activity, while
in the present study psychic anxiety was significantly and
positively correlated with MAO In unipolar females, and
negatively, although insignificantly correlated with platelet MAO
activity In unipolar males.
Athough not previously reported In the literature, the
present data point to an overall negative association between
platelet MAO activity and symptoms which are related to somatic
disturbances. In addition to the negative correlation observed
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between platelet MAO activity and somatic anxiety, negative
correlations were also observed between platelet MAO activity and
both somatic and genital symptoms, with somatic symptoms
correlating with platelet MAO activity in both the total and
unipolar groups as well as in the respective female subgroups, and
genital symptoms correlating with platelet MAO activity in the
total group. These findings suggest that lower levels of platelet
MAO activity may be associated with greater physiological
disturbance which manifests itself in somatic symptoms.
The other nonendogenous symptoms observed to be
significantly correlated with platelet MAO activity in this study,
obsessional ity, paranoia, and depressed mood, have also not
previously been reported in the literature. In females, higher
platelet MAO activity was observed to be associated with more
obsessional thinking, while in males and in unipolar patients,
lower platelet MAO activity was observed to be related to
paranoia. The correlation between depressed mood and platelet MAO
activity attained significance in only the subgroup of male
unipolar patients. Previous studies have reported relationships
between these symptoms and post-dexamethasone Cortisol (Schatzberg
et al., 1987), however, further research is needed in order to
determine whether relationships between obsessional ity, paranoia,
and depressed mood and platelet MAO activity are more than
random
findings.
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Platelet MAO activity anri
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Of the four biochemical measures of depression studied,
platelet MAO activty was the most stongly associated with
suicidal ity. Positive correlations were observed between platelet
MAO activity and suicide in both the total and unipolar groups.
When the sexes were examined separately, this relationship was
observed to be strongest in females. In the regression analysis,
suicide was observed to be one of five variables to explain the
total variance of platelet MAO activity.
Levels of platelet MAO activity were also observed to be
significantly higher in patients with higher ratings of current
suicidal ity (assessed at the time of biochemical measurement using
the HRSD suicide item) as compared to patients with lower current
suicide ratings, even after the effects of age, sex, and severity
had been controlled for. This finding suggests that the positive
association observed between platelet MAO activity and suicide is
not due simply to the higher levels of platelet MAO activity
observed in women. Although not significant, higher levels of
platelet MAO activity were also observed in patients with higher
ratings of past suicldality (based on ratings from the SADS
suicidal tendencies item) as compared to patients with lower
ratings of past suicldality.
The present study is one of the first to report a positive
association between platelet MAO activity and suicide. Other
studies have either reported a negative relationship (Gottfries et
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al., 1980, Buchsbaum et al., 1981), or no relationship between
MAO activity and suicide (Oreland et al., 1981; Reveley et al.,
1981). Data in this study may differ from previous reports due to
several factors. Unlike other studies, in this study, significant
positive associations between platelet MAO activity and
suicidal ity were observed when both ratings of current suicidal ity
and biochemical measurement were obtained during the same one week
period. In addition, the current study focused on depressed
patients only, rather than examining suicide across diagnostic
groups. The methodological approach used in this study may have
contributed to the contrasting findings.
Inter-relationship of post-dexamethasone Cortisol, platelet MAO
activity and clinical symptoms
In this study post-dexamethasone Cortisol was observed to
correlate positively and significantly with platelet MAO activity.
This finding is consistent with previous reports of a positive
association between these two biological meaures (Meltzer et al.,
1988; Schatzberg et al., 1983b; Schatzberg et al., 1985;
Schatzberg et al., 1987). It must be noted however, that in two of
these studies (Schatzberg et al., 1983b and Schatzberg et al.,
1985), a subset of patients (N = 26 and N = 50 respectively) from
the current study were reported on.
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Although the biological relationship between these two
measures remains unclear, it is possible that both are related to
an endogenous subtype of depressive disorder. In this study post-
dexamethasone Cortisol and platelet MAO activity were observed to
be identically although insignificantly correlated with
endogeneity (r = .21, p = .06), as well as being significantly and
positively correlated with endogeneity in the subgroup of females.
In this study no significant correlations were observed
between either post-dexamethasone Cortisol or platelet MAO
activity and severity. This finding is in contrast to the study of
Schatzberg et al. (1985) which found both measures to be modestly,
but significantly, correlated with total HRSD scores in a subset
(N = 50) of the same patients currently studied.
The one symptom that was observed to be negatively
correlated with both post-dexamethasone Cortisol and platelet MAO
activity in the total group, as well as in several of the
subgroups (the total female group, the unipolar group and the
group of unipolar males) was somatic anxiety. This finding
contrasts with a hypothesis proposed by Georgotas et al. (1986)
which suggests that platelet MAO activity is associated with
higher anxiety and agitation, symptoms which in turn account for
some cases of DST non-suppression. The current findings suggest
rather, that a lack of anxiety, at least of a somatic type, may be
associated with higher levels of post-dexamethasone Cortisol and
platelet MAO activity, and that overall, higher levels of both
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biological measures may be related to a depressive syndrome
involving more endogeneity and less anxiety.
^ntgr-relationshin of MHPG. UFr and minir;>i
^^YTt-m
In this study MHPG was observed to correlate positively and
significantly with UFC in the total group of patients for whom
these measures were available. This finding is consistent with a
report of Rosenbaum et al. (1983) and others which found strong
significant relationships betwen these two biological measures.
In this study neither MHPG nor UFC were significantly
correlated with either severity or endogeneity. In addition, no
clear pattern emerged between both of these biological measures
and clinical symptoms. Obsess ionality was observed to be
significantly and positively correlated with both MHPG and UFC in
the group of unipolar patients, however the other two symptoms
(paranoia and agitation) observed to be significantly correlated
with both measures were correlated in opposite directions with
each biological measure. Since only a subset of the sample (N= 38)
had both MHPG and UFC measurements, it is possible that the
overall lack of associations between these two measures and
clinical symptoms is due to the small sample size, and that more
meaningful relationships would emerge in a larger sample of
patients.
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In this study separate correlation matrices were calculated
for the total group of patients (a combined group of unipolar and
bipolar patients), and for the unipolar group of patients. Given
the more homogeneous nature of the unipolar group, it was
anticipated that to some extent, different patterns of
relationships between the biological measures and clinical
symptoms would be observed in the unipolar group, while also
anticipating a large degree of overlap between findings in the
two groups due to the majority of the total sample being diagnosed
as unipolar. As anticipated, several variables were observed to be
significantly correlated with the biological measures in the
unipolar group, but not in the total group, and in some cases
stronger associations were observed in the unipolar group as
compared to the total group.
In the correlations between post-dexamethasone Cortisol and
clinical symptoms, the variables that were observed to be
significantly correlated in the unipolar group but not in the
total group were length of illness (significant in the total
unipolar group), somatic symptoms, and obsessional ity (significant
in the unipolar female subgroup). A stronger relationship between
post-dexamethasone Cortisol and somatic anxiety was observed in
the unipolar group.
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In the correlations between UFC and clinical symptoms in the
unipolar group, relationships emerged between UFC and psychomotor
retardation (in the total unipolar group) and obsessional ity (in
the male subgroup); these relationships were not observed to be
significant in the total group. The association between overt
anger and UFC was stronger in the unipolar group of patients than
in the total group, although in both, the correlations were
statistically significant.
Significant relationships between MHPG and obsessional ity,
agitation, (in the total unipolar group) and number of suicide
attempts (in the unipolar female subgroup) were observed in
unipolar patients but not in the total group of patients.
In the correlations between platelet MAO activity and
clinical symptoms, two variables, endogeneity and paranoia, were
significantly related to platelet MAO activity in the total
unipolar group, but not in the total group of patients. Psychic
anxiety was also observed to be significantly related to platelet
MAO activity in unipolar females but not in the total group of
females. An even stronger relationship was observed between
platelet MAO activity and suicide in the unipolar group as
compared to the total group, although again in both, the
correlations were significant.
These data point to the usefulness of studying subtypes of
depressive disorders. Although not reported in this study,
different relationships between biological measures and clinical
symptoms were observed in the bipolar group of patients. The data
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presented here suggest that symptom patterns may vary in subtypes
of depressive disorders and that these symptoms may relate
differently to biological measures in subtypes of depressive
disorders
.
PeUtjonships between biological mp;..nr.s and rlinin.i symptom., in
female and male patipnt-<s
In this study a greater number of significant correlations
were observed between biological measures and clinical symptoms in
the female group of patients than in the male subgroup. As stated
previously, this finding may be due to the larger sample size of
the female subgroup, but may also reflect differences in both
biological measures and in symptom patterns in females and males.
Very few symptoms were observed to correlate significantly
with the biological measures in both the female and male
subgroups. In fact, almost completely opposite patterns of
relationships were observed in female and male paients. While
these differences will not be discussed in detail here. Tables 5
through 13 demonstrate this pattern clearly.
Of the many symptoms examined in this study, only two were
correlated similarly and significantly with biological measures in
females and males. Somatic anxiety was correlated significantly
with post-dexamethasone Cortisol in both unipolar females and
males, as well as being correlated significantly with platelet MAO
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activity in the total female and male subgroups. Guilt was
significantly correlated with post-dexamethasone Cortisol in both
the unipolar female and male subgroups.
Further studies are needed in order to help determine
whether the greater number of symptoms observed to be related to
biological measures in females in this study, is due to increased
symptomatic complaints in females, different biological mechanisms
in females and males, or can simply be attributed to random
findings.
Summary
In this study complex relationships were observed between
biological measures and clinical correlates in a total group of 83
patients, a subgroup of 67 unipolar major patients, and in female
and male patients in these two groups. Data from all correlations
which attained significance levels of p < .05 were presented and
discussed in an attempt to most fully explore the relationships
between four biological measures of depression and clinical signs
and symptoms. Due to the large number of correlations calculated
in this study however, the risk of a Type II error (a false
positive identification of significance due to chance alone) was
quite high. After adjusting statistically for this possibility
using the Bonferroni correction, fewer, yet significant
correlations were still observed between the biological measures
and clinical correlates. These statistically more robust
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correlations, in conjunction with the regression analyses, provide
the most reliable data concerning relationships between biological
measures and clinical correlates.
The four key symptoms observed to be related to post-
dexamethasone Cortisol based on the more stringent criteria were
somatic anxiety, guilt, psychosis and endogeneity. Three of these
symptoms, guilt, psychosis and endogeneity explained 41 % of the
total variance of post-dexamethasone Cortisol, while somatic
anxiety was observed to be significantly correlated with post-
dexamethasone Cortisol in the total and unipolar groups even after
Bonferroni correction.
UFC was observed to be primarily related to five symptoms
(overt anger, subjective anger, suicidal tendencies, agitation,
and obsessional ity), as well as to sex and severity after more
stringent statistical criteria were applied. As reported earlier,
overt anger, subjective anger, suicidal tendencies, sex, and
severity explained 41 % of the variance of UFC. Correlations
between UFC and agitation and UFC and subjective anger remained
statistically significant in the total group, after Bonferroni
correction, as did correlations between UFC and agitation,
subjective anger, and overt anger in the unipolar group.
Obsessional ity remained significantly correlated with UFC in the
male unipolar subgroup after statistical correction.
No significant correlations were observed between MHPG and
clinical symptoms after Bonferroni correction. The regression
analysis in which sex, agitation, and obsessionality were
observed
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to explain 32 % of the total variance of MHPG probably provides
the best measure of relationships between MHPG and clincal
symptoms.
The five key symptoms observed to be related to platelet MAO
activity using more stringent statistical criteria were somatic
anxiety, suicide, somatic symptoms, obsessional ity, and paranoia,
as well as sex and severity. Forty-three percent of the variance
of platelet MAO activity was explained by somatic anxiety,
suicide, somatic symptoms, sex, and severity. Somatic anxiety was
also observed to correlate significantly with platelet MAO
activity in the total group and total group of males after
Bonferroni correction. In the female subgroup and in unipolar
males, obsessionality remained significantly correlated with
platelet MAO activity after statistical correction, as did
paranoia in the subgroup of unipolar males.
These data point to essentially unique relationships between
each of the four biochemicals and clinical symptoms. Only three of
the symptoms, somatic anxiety, agitation, and obsessionality were
observed to correlate with more than one biochemical measure after
Bonferroni correction. Further studies are needed to explore
whether even these more robustly related symptoms are best
explained by chance alone, or can be replicated in the future.
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APPENDIX
Hamilton Rating Scale for neoressin^^
Depressed Mnor^
0. Absent
1. These feeling states indicated only on questioning
2. These feeling states spontaneously reported verbally
3. Communicates feeling states non-verbally-i.e.
, through
facial expression, posture, voice, and tendency to weep
4. Patient reports virtually only these feeling states in his
spontaneous verbal and non-verbal communication
Feelings of Guilt
0. Absent
1. Self-reproach, feels he has let people down
2. Ideas of guilt or rumination over past errors or sinful
deeds
3. Present illness is a punishment, delusions of guilt
4. Hears accusatory or denunciatory voices and/or experiences
threatening visual hallucinations
Suicide
0
. Absent
1. Feels life is not worth living
2. Wishes he were dead or any thoughts of possible death to
self
3. Suicide ideas or gesture
4. Attempts at suicide (any serious attempt rates 4)
Insomnia Early
0. No difficulty falling asleep
1. Complains of occasional difficulty falling asleep - i.e.
more than 5^ hour
2. Complains of nightly difficulty falling asleep
Insomnia Middle
0. No difficulty
1. Patient complains of being restless and disturbed during the
night
2. Waking during the night - any getting out of bed rates 2
(except for purposes of voiding)
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. Insomnia Lat-p
0. No difficulty
2* nn^i?! i"" f °^ ""^'^^^^ but goes back to sleep2. U able to fall asleep again if gets out of bed
7. Work and ActivitiPR
0. No difficulty
1. Thoughts and feelings of incapacity, fatigue or weakness
related to activities work or hobbies
2. Loss of interest in activity: hobbies or work- either
directly reported by patient, or indirectly in listlessness,
indecision and vacillation (feels has to push self to work
or activities)
3. Decrease in actual time spent in activities or decrease in
productivity. In hospital, rate 3 if patient does not spend
at least three hours a day in activities (hospital job or
hobbies) exclusive of ward chores
4. Stopped working because of present illness. In hospital,
rate 4 if patient engages in no activities except ward
chores, or if patient fails to perform ward chores
unassisted
8. Retardation
0. Normal speech and thought
1. Slight retardation at interview
2. Obvious retardation at interview
3. Interview difficult
4. Complete stupor
9. Agitation
0 . None
1. "Playing with" hands, hair etc.
2. Hand-wringing, nail biting, hair-pulling, biting of lips
etc.
10 . Anxiety Psychic
0. No difficulty
1. Subjective tension and irritability
2. Worrying about minor matters
3. Apprehensive attitude apparent in face or speech
4. Fears, expressed without questioning
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11. Anxiety Snmai-^r^
0 Absent { Physiological concomitants of anxiety,
2 Moderate
'"''5 as: Gastrointestinal- dry mouth:
\\ ttlT b^fchiig'^'"''^^' ^^-P^'
4. Incapacitating
{ cardio-vascular- palpitations, headaches,
respiratory- hyperventilation, sighing,
urinary frequency, sweating
12- Somatic Symptoms fla stro-lnhpsh i nai
0
. None
^' but eating without staff encouragement.Heavy feelings m abdomen
2. Difficulty eating without staff urging, requests or requireslaxatives or medication for bowels or medication for G I
symptoms
13. Somatic Svmptoms General
0
. None
1. Heaviness in limbs, back or head. Backaches, headache,
muscle aches, loss of energy and fatigability
2. Any clear-cut symptom rates 2
14. Genital Symptoms
0, Absent Symptoms such as: Loss of libido
^' '^ll^ Menstrual disturbances
2. Severe
15. Hypochondriasis
0. Not present
1. Self-absortion (bodily)
2. Preoccupation with health
3. Frequent complaints, requests for help, etc.
4. Hypochondriacal delusions
16. Weight Change
A. When rating by history (pre-treatment)
0. No weight loss
1. Probable weight loss associated with present illness
2. Definite (according to patient) weight loss
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16. Weight Change
B. On weekly ratings by ward psychiatrist, when actual weightchanges are measured n
0. Less than 1 lb. weight loss in one week
1. One to 2 lb. weight loss in one week
2. Greater than 2 lb. weight loss in week
17. Insight
0. Acknowledges being depressed and ill
1. Acknowledges illness but attributes cause to bad food,
climate, overwork, virus, need of rest etc.
2. Denies being ill at all
18. Diurnal Variation
0. Absent (no variation in symptoms a.m. /p.m.)
1. Mild (minimal variation in symptoms a.m. /p.m.)
2. Severe (significant variation in symptoms a.m. /p.m.)
19. Depersonalization and Derealization
0. Absent Such as: Feelings of unreality, nihilistic
1. Mild ideas
2. Moderate
3 . Severe ^
4. Incapacitating
20. Paranoid Symptoms
0 . None
1. Suspicious
2. Ideas of reference
3. Delusions of reference and persecution
4. Persecutory hallucinations
21. Obsessional and Compulsive Symptoms
0. Absent
1. Mild
2. Severe
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